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NIGRO-STRIATAL LESIONS A}ID DRUGS

ABSTRACT

Lesioning the nigro-striatal dopamine neuron system
produces aphagia and adipsia with an intensity proportional to the size of the lesion.

Those rats which received

small lesions produced by a 1 mA current for a 15 second
duration of the nigro-striatal system initially lost weight
and then spontaneously recovered from that loss.

Pretreat-

ment with alpha-methyl-para-tyrosine (50 mg/kg) or haloperidol

(0.4

mg/kg) given twice a day for a three-day pe-

riod prior to lesioning facilitated the recovery.
large lesions

(2mA

for

JO

When

sec) were used to destroy this

dopaminergic neuron system,

a severe aphagia and adipsia

resulting in death occurred in all saline treated animals .
Haloperidol

(2 mg/kg)

or morphine sulfate

(JO

mg/kg) in-

jected twice a day for six days preceding extensive nigrostriatal destruction promoted survival.

The pharmacologi-

cal denervation of dopaminergic receptors produced by
haloperidol, morphine sulfate, or alpha-methyl-para-tyrosine prior to surgical destruction pf the nigro-striatal
pathway i? felt to facilitate recovery.
Symptoms of morphine withdrawal such as, wet shakes,
ptosis, weight loss and hypothermia were enhanced when lesions were made in the nigro-striatal tract prior to and
following the production of morphine dependence.

This ex-

acerbation of the primary abstinence syndrome was seen at
either of two different terminal doses of morphine sulfate.

ii

Apomorphine,

a dopamine receptor stimulant,- was effective in

reducing the withdrawal wet sha kes in these lesioned animals.
The administration of apomorphine to intact withdrawn rats
also resulted in a signi fi c ant decrease in wet shakes. The
intensity of morphine withdrawal aggr e ssion observed in response to social grouping of the animals seventy-two hours
after the termination of morphine administration was decreased by nigro-striatal lesioning.

Destruction of the

medial forebrain bundle in morphine dependent rats results
in increased withdrawa l

ptosis, temperature and weight loss.

These results suggest a role for brain noradrenergic and
dopaminergic neuronal syst ems in morphine withdrawal.
particular, withdra wal wet shakes seem to be related to
dopaminergic mechanisms.

iii
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I.

INTRODUCTION

The exis te nce of the nigro-striatal pathway arising in
the substantia nigra and terminating in the neostriatum is
well established by histological (Anden et al., 1964; Anden
~al.,

1965), biochemical (Anden et al., 1964; Poirier and

Sourkes ,. 1965) and electromicroscopic (Hokfelt and Ungerstedt, 1969) determinations.

The nigro-striatal neuron sys-

tem is known to regulate the dopamine content o:f the neostriatum (Anden. et al., 1964; Anden et al., 1965).

The phy-,

siological importance of this system is evident froffi its involvement in mo t or function, mental processes,

thei'moregu-

lation and normal feeding behavior (Anden et al., 1966b;
Fuxe et al.,

1 970).

The function of this dopamine system is

particularly int eresting in connection with the actions of
a number of ps y c h opharmacological agents such a s apomorphine
(Anden et al., 1967; Ernst, 1967), morphine (Puri et al.,
1973) and neuro1.eptics (Anden et al., 1971) which are known
to in:f'luence do p aminergic function. The objective of this
study is to investigate the interaction between the effects
of lesioning the nigro-striatal neuron system and
pharmacological agents affecting dopamine receptors.
The ascendi ng fibers of the nigro-striatal system
originate mainly from the dopamine cell bodies situated in
the zona compac ta of the substantia nig ra.

1

The fibers be-

2

come aggregated in a bundle situated just medial and ventromedial to the lernniscus medialis in the area of the nucleus
ventralis tegmenti.

This bundle lies dorso medial to the

ventral part of the crus cerebri in the H

2

area of Forel be-

fore it enters the ro s tral part of the crus cerebri.

After

entering the crus cerebri the tract diverges into the internal capsule to innervate the neostriatum (Anden et al.,
1964; Anden et al., 1965; Poirier and Sourkes, 1965; Faull
and Laverty, 1969).

This system is of great importance for

normal movements and postures.

The symptoms of rigidity,

hypokinesia and tremor found in parkinsonism are probably
due to the degeneration of the nigro-striatal system (Hornykiewicz, 1966).

The pathophysiology of schizophrenia may

be in part due to the activity of dopamine at its receptor
sites in the striatum (Klawans et al., 1972).

A role for

dopamine neurons in thermoregulation has been suggested
since apomorphine decreases body temperature via a central
action (Fuxe and Sjogrist, 1972).

The ni g ro-striatal neu-

rons appear to be necessary for normal eating and drinking
behavior (Ungerstedt, 1970, 1971; Oltsman and Harvey, 1972).
Unilateral lesions of the corpus striatum or the nigrostriatal dopamine system are known to produce asymmetric
movements and postures (Poirier et al., 1965; Anden et al.,
1966).

Lesioned animals show a pro~ounced rotational be-

havior which is linked to differences in dopamine receptor
activity on two sides of the brain (Anden et al., 1966a).

3

Three to four days after unilateral removal· of the nigrostriatal system there is a lack of orienting response to all
sensory stimuli on the side contralateral to the lesion
(Ungerstedt, 197J).

The period from five days to two months

after the operation is characterized by partial recovery of
sensory function (Ungerstedt, 1973).
nigro-striatal system, bilaterally,

Degeneration of the in the rat has been

shown to result in the development of adipsia and aphagia
(Ungerstedt et al.,

1970, 1971).

Zigmond and Stricker (1972,

1973) have al s o found that depletion of brain dopamine was
critical for the production of adipsia and aphagia.

The

adipsic and aphagic syndrome seen after nigro-striatal destruction is severe and if not force-fed animals die several
days after lesioning (Ungerstedt, 1970, 1971; Oltsman and
Harvey, 1972).
adipsia,

Force-fed animals recover from aphagia and

in a predictable sequence of stages culminating in

the ability to maintain their body weight on food pellets
and water (Marshall and Teitelbaum, 1973).

Recovery of

feeding behavior has been suggested to involve a denervation
supersensitivity mechanism (Glick~ al.,

1 9 72).

Supersensi-

tivity may be defined as the phenomenon in which the amount
of a neurotransmitter required to produce a given biological
response is less than normal.

Thus,

the one consistent sign

of supersensitivity is a shift to the left of the dose response curve (Fleming~ al., 1973).
Supersensitivity in addition to being a useful model
in explaining recovery of feeding behavior has also been

4

forwarded to ' explaining dependence on narcotics (Jaffe and
Sharpless, 1968; Collier, 1969).

Based upon results from

morphine withdrawal aggression it has been suggested that
central dopamine receptors are supersensitized during chronic morphine administration.

Morphine withdrawal aggression

in dependent animals can be selectively potentiated by
dopaminergic stimulating agents and blocked by drugs which
block dopamine receptors

(Puri~ al.,

1972; Puri and Lal, 1973).

1971; Lal and Puri,

Further evidence for the inter-

action between brain dopamine and morphine comes from biochemical studies.

Acute morphine elevates brain hornovanil-

lie acid and J- 4 dihydroxyphenylacetic acid (Fukui and
Tagaki, 1972; Kus c hinsky and Hornykiewicz, 1972), increases
the synthesis of labeled dopamine from labeled tyrosine in
brain (Clouet and Ratner, 1970; Fukui et al., 1972; Smith
~ al.,

1970, 1972 )' and accelerates the disappearance of

dopamine after the administration of alpha-methyl-paratyrosine (Gunne ~ aJ_., 1969; Puri et al., 1973).

Based up-

on these studies it was proposed that acute administration
of morphine blocks dopamine receptors.

Chronic administra-

tion of morphine therefore wo-uld produce a persistent bJ_ockade of dopamine receptors and cause the development of latent supersensit i vity of central dopamine receptors.

This

supersensitivity may therefore contribute to the morphine
withdrawal synd rome.
Treatment with haloperidol (Gia.nutsos et al., 197 4 a,
1975)

and methy l-para-tyrosine (Tarsy and Baldessarini, 1973)

5

has also been shown to produce a supersensitivity of dopamine
receptors in the central nervous system.

Haloperidol is a

potent neuroleptic that is known to block dopamine receptors (Janssen, 1967; Anden et al., 1971). The dopamine receptor supersensitivity produced by chronic administration
.o f haloperidol is manifested by an enhanced stereotypy and
aggression in response to small otherwise ineffective doses
of apomorphine (Gianutsos

.!:..!

al., l974a).

Apomorphine has

been sho>\TI to effectively decrease turnover of dopamine in
haloperidol-treated rats at doses which were without effect
in drug-naive rats (Gianutsos et~., 1975).

A shift in

the dose response curve in the direction of increased sensitivity was found in response to apomorphine,

a dopaminergic

stimulant, after withdrawal of chronically administered
alpha-methyl-para-tyrosine (Tarsy and Baldessarini, 1973).
Alpha-methyl-para-tyrosine is a well known inhibitor of cate cholamine synthesis (Nagatsu et al., 1964).

Apomorphine,

which has been used in these studies to show increased sensi ti vi ty,

is believed to stimulate the dopaminergic recep-

tors in the central nervous system (Anden et al., 1967;
Ernst, 1967).

Biochemical studies have shmvn that apomor-

phine decreases the turnover rate

o~

striatal dopamine;

this

effect is completely blocked by haloperidol (Anden et al .,
1967; Persson, 1970; Anden and Becard, 1971; Lahti et al.,
1972; Puri, 1973).
This investigation is focused on the nigro-striatal neuron system and dopaminergic supersensitivity.

These factors

6

were studied in relation to aphagia, adipsia and the morphine withdrawal syndrome.

Nigro-striatal lesions will be

made and body weight changes recorded.
tion of the lesion,
saline,

Frio~

to the produc-

animals will be treated with either

alpha-methyl-para-tyrosine, a blocker of catechol-

amine synthesis (Nagatsu et al., 1964), haloperidol, a dopaminergic blocking agent (Janssen, 1967; Van Rossum, 1967;
Anden et al., 1970), or morphine which may also block dopaminergic receptors (Puri et~.,

l97J).

Drug treated and

cbntrol groups will be compared with respect to lesion induced weight changes and lethality.
Nigro-striatal lesions will be produced both prior to
and subsequent to the production of morphine dependence.
After the abrupt termination of morphine injections subjects will be observed for the symptoms of morphine withdrawal.

Narcotic withdrawal symptoms will be compared between

lesioned and non-lesioned groups.

The dopaminergic stimu-

lating agent apomorphine (Anden et al., 1967; Ernst, 1967)
will be administered to both intact and nigro-striatal lesioned morphine withdrawn subjects to further assess the
role of dopamine receptor activity in the abstinence phenomena.

In order to determine if the results are specific

for the dopaminergic system the medial fore brain bundle,
a nor-adrenergic and serotonergic neuron system, will also
be lesioned after the production of dependence and abstinence signs observed.
This research has the following significance.

First-

7

ly,

evidence for the role of the nigro-str{atal dopamine neu-

rons in aphagia and adipsia will be gathered.

Secondly,

it

will clarify the role of receptor supersensitivity in recovery from nigro-striatal lesioning and in the morphine
withdrawal syndrome.

'Ihirdly,

it will give insight into the

role of this dopamine system in narcotic dependence.

II.
A.

LITERATURE SURVEY

Central Ne rvous Syst e m Dopaminergic Pathways
The dopamine neuron system discovered so far are two

large ascending fiber systems and one small dopamine neuron
system.

The existence of these dopaminergic pathways has

been demonst ra ted through studies employi ng lesions,

stimu-

lating electrodes, biochemical and histochemical techniques.
Based upon these studies the following dopaminergic pathways have been described:
1)

Mesolimbic Dopamine Neur·Jns

2)

Tubero-infundibular Dopamine Neurons

J)

Nigro-Neostriatal Dopamine Neurons

l)

Mesolimbic Dopamine Neurons
The mesolimbic dopamine neurons have their cell bodies

in the area surrounding the nucleus interpeduncularis and
fibers from these cell bodies terminate in the tuberculum
olfactorium, nucleus accumbens,

the dorsolateral part of the

nucleus interstitialia striae terminalis and in the nucleus
amygdaloideus centralis (Anden et al., l966a). Dopaminergic
fibers of this system run medially to the nigro-neostriatal
dopamine fibers whereas cranially they mainly lie ventral
to the nigro-neostriatal dopamine fibers.

The mesolimbic

dopamine neurons probably contain less dopamine than does
nigro-neostriatal dopamine neurons.
8

This is probably due

9

to the fact that the terminal network of each mesolimbic
dopamine neurons is much smaller than that of the nigroneostria tal dopamine neurons (Anden et ~.-, 1966b; Fuxe et
al., 1970).
Lesions placed at the level of the rostral hypothalamus which specifically interrupt the pathway to the mesolimbic area are found to modify neuroleptic catalepsy.
These lesions caused an initial potentiation followed by a
reduction in the cataleptic effect of neuroleptic agents
but cause a potentiation of cholinergic catalepsy at all
times of testing (Costall and Naylor, 1974).

The mesolimb-

ic area thus appears to be involved with the mediation of
neuroleptic catalepsy and the cholinergic dopaminergic balance controlling cataleptic

beha~~br

~ould

also appear to

involve the mesolimbic dopamine neurons (Costall and Naylor,
1974a).

Lesions of the dopaminergic mesolimbic innervation

partially reduce morphine catatonia (costall and Naylor,
1974b). · Although stereotypy has been considered by many
purely in terms of extrapyramidal actions, studies employing apomorphine and ET 495 have shown that mesolimbic functions are important for the initiation of stereotyped responses (Costall and Naylor, 197Jc).

Ablation of the mesa-

limbic innervation reduce the weaker components of methylphenidate stereotypy (Costall and Naylor, 1974c).
2)

Tubero-infundibular Dopamine Neurons
The tubero-infundibular dopamine neurons have their

10

cell bodies mainly localized to the anterior part of the
nucleus annuatus and anterior periventricular nuclei.

The

axons of this system run ventrally toward the lateral b6rder
of the median eminence (Fuxe, 1963; I<'uxe and Hokfelt, 1966,

1969).

In the external layer of the medial eminence, the

axons give rise to a densely packed plexus of dopaminergic
nerve terminals, which exerts ah axo-axonic influence in the
layer (Hokfelt, 1967).
This very short dopaminergic intrahypothalamic system
regulates the discharge of the releasing and inhibiting factors from the median eminence (Fuxe ~al., 1970).

The re-

lea8e of dopamine in the median eminence acts locally on
terminals storing luteinizing hormone releasing factor
(LHRF) to inhibit the release of LHRF from the medial eminence.

This system also participates in mediating the nega-

tive feedback action of estrogen and testosterone on gonadotropic secretion, because estrogen and testosterone markedly
increase the turnover of the tubero-infundibular dopamine
neurons of castrated rats, resulti·ng in increased release of
dopamine in this area (Fuxe et al., 1967, 1969).

The block-

ade of ovulation by synthetic estrogen and its derivatives
may at least partly be mediated via activation of the neuron
system (Fuxe and Hokfelt, 1969).

This system is also high-

ly sensitive to prolactin, which markedly increases the
turnover of dopamine in the tubero-infundibular dopamine
neurons (Fuxe and Hokfelt, 1969, 1970).

11

J)

Nigro-neostriatal Dopamine Neurons
The nigro-neostriatal system seems to originate mainly

1964).

in the pars compacta of the subst a ntia nigra (Anden,

Support for this comes from fluorescence microscopy and the
high dopamine content observed in this area (Hornykiewicz,

1963).

Unilateral pars compacta lesions result in a sixty

per cent lowering of the dopamine level in the
atum of the

operat~d

corpu~

stri-

side when compared with the unoperated

side (Faull and Laverty,

1969).

The caudate nucleus and

putamen shows a fairly strong green to yellow fluorescence
due to the high dopamine content.

This fluorescence was re-

duced in animals with lesions of the substantia nigra.

A

clear correlation was found between the fluorescence reduction and the extent of destruction of the pars compacta
(And en,

1964).

Some cell bodies are also found in the zona

reticulata and the pars lateralis of the substantia nigra,
which also belong to the nigro-neostriatal dopamine neurons
(Fuxe et al.,

1970).

Recently,

studies after removal of the

nucleus caudatus putamen suggest that the cell bodies in
the ventrolateral part of the midbrain tegrnentum belong to
this large uncrossed neuron system,

inasmuch as they show

marked reduction in fluorescence intensity and signs of
atrophy after such operations (Fuxe et al.,

1970).

There

is now a virtually complete picture of the distribution of
these dopamine fibers.

Upon leaving the pars compacta of

the substantia nigra, most of the nigro-neostriatal dopamine

12

fibers become aggregated in a bundle which ascends

just medi-

al and dorso medial to the ventral part of the crus cerebri.
At the level of the posterior part of the medial eminence,
the bundle turns to the ventralrostral part of the crus cerebri and enters and diverges into the rentrolenticular part
of the internal capsule.

Running rostrally and dorsally in

the internal capsule, the fibers then ascend in the fibers
of the internal capsule to innerva te the neostriatum (Anden
et al., 1965).
Biochemical and histochemical investigation have
yielded some quantitative data on the unilateral
striatal dopamine system in the rat.
making up this

syst~m

nigro~neo-

The number of neurons

is 3500 on the average.

There are

-10
about 1.2 x 10 .
grams of dopamine per neuron with

termi~

nals containing fifty times more dopamine than the cell
bodies.

There are approximately 500,000 varicosities in the

terminals, each with an average diameter of 0.4u, containing
2.5 x 10

-16

grams of dopamine and has a dopamine concentra-

tion of around 8,000 ug/grwet weight.

One dopamine cell

body of the substantia nigra, with a mean diameter of 30u,
contains 2,5 x 10

-18

grams and has a dopamine concentra-

tion of from 60 to 200 ug/gr (Anden et al., 1966c).
a.

Electric stimulation of the nigro-neostriatal pathway
The direct electrical stimulation of either the cau-

date nucleus or the pars compacta of the substantia nigra
causes a frequency and intensity related release of H-3

lJ

dopamine into the cerebrospinal fluid (Von Voightlander and
Moore, 1971, 1 9 72) and also into ventricles
er and Moore, 1971).

(Von Voightland-

These results imply that dopamine is

a neurotransmitter of the nigro-neostriatal pathway.

There

is evidence to indicate that dopamine may function as an
inhibitory neurotransmitter at the terminals of the nigro-·
neostriatal pathway.

Bloom et al.,

(1965),

demonstrated a

primarily i rihibi tory action of dopamine when it was applied
micro-iontrophoretically to caudate neurons.
neurons tha t

Most of the

respond to dopamine are inhibited by exogeneous

dopamine applied in the caudate nucleus of anes.thetized and
decerebrated cats {McLell a n and York, 1967; York 1970).
Following the application of dopamine iontrophoretically
from multibarrel micropipette assemblies ne a r

caudate cells,

the rate of discharge of fifty to sixty per cent of these
neurons is depressed, while the spike rate of approximately
ten per cent of the cells is facilitated.

Electrical stim-

ulation of substantia nigra evokes depressant and facillatory responses from individually recorded nucleus neurons (Connor, 1968, 1970).
Catecholamine involvement in the phenomenon of intracranial self stimulation is well known.

Until recently,

major role has been assigned to noradrenergic nerves.

the

This

has been challenged by neuroanatomical and histochemical
evidence of a possible dopaminergic involvement in intracranial self-stimulation (Phillips and Fibiger, 1973).

When
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the facilatory effects of d and l
self-stimulation were assessed,

isomers of amphetamine on

it was found that the two

isomers were equipotent (Phillips and Fibiger, l97J). These
data would seem to indicate that the dopaminergic systems
in part subserves
b.

positiv~

reinforcement.

Motor functions
The nigro-neostriatal neurons play an important role

in normal movement and postures.

Degeneration of the sys-

tern is believed to be the cause of symptoms such as rigidity, hypokinesia and tremors found in parkinsonism (Hornykiewicz, 1966).

In agreement with this it has been found

possible to restore normal motor functions in Parkinsonian
patients by treatment with L-dopa (Cotzias et al., 1967).
The drug-induced stimulation of the nigro-neostriatal
pathway causes an induction of locomotion,

stereotyped be-

haviors and finally compulsive gnawing (Randrup and Munkvad,
1968; Fuxe and Ungerstedt, 1970).

Thus the changes in

these behaviors involve the stimulation of dopaminergic receptors.

Similar results were obtained when animals were

treated with L-dopa,

the precursor of dopamine,

dopa decarboxylase illl'J.ibi ti on.

following

Locomotor activity was mark-

edly increased (Bartholini et al., 1969; Butcher et al.,
1970).

The increase in locomotor activity is mainly com-

posed of stereotyped movements (Butcher et al., 1970).

The

systemic administration of apomorphine produces stereotyped behavior in rats which is characterized by continuous
and compulsive sniffing, licking and gnawing (Ernst, 1965).
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The results of several studies have supported the hypothesis
that stereotyped behaviors induced by apomorphine or by
amphetamine is due to increased dopamine receptors activity
in the neostriatum (Ernst, 1969; Fuxe and Ungerstedt, 1970).
Unilateral lesions of the corpus striatum or the nigrbstriatal dopamine system are known to produce asymmetries in
movemen t

and posture (Poiri~r et al., 1965; Anden

i966a ) .

The difference between the two sides of the brain

t l al.,

may be further aggravated by treatment with drugs that release dopamine from the non-lesioned side.

Such animals show

a pronounced rotational behavior (Anden et al., 1966a).

The

rotational behavior is further linked to the differences in
dopamine levels on the two sides of the brain by finding
that tinilateral striatal injections o f dopamine cause the
rats t o turn or slowly rotate away from the side where dopamine was injected (Ungerstedt et al., 1969).

Spontaneous

rotatio ns toward the intact side is seen twenty-four to
thirty-four hours after a lesion of the nigrostriatal dopamine s y stem.

The direction of the rotation as well as the

time p o int of its occurrence is indicative of a degeneration
release of dopamine from_ the lesioned side (Ungerstedt,

1973).

In a chronically lesioned animal there is a striking

difference bet ween the effects of dopamine-releasing drugs
and dnpamine receptor-stimulating drugs.

Amphetamine causes

the ani mal to rotate toward its lesioned side,

apomorphine

causes .i t to r o tate toward its intact side (Ungerstedt,

1973).

These r esuJ_ts indicate that amphetamine preferenti-
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ally influences the non-lesioned side, whereas apomorphine
exerts its strongest effect on the denervated side.
c.

Mental functions
It is now accepted that stereotyped behavior induced

by amphetamine or apomorphine is principally due to the increased dopaminergic neurotransmission in the neostriatum.
Stereotyped behavior is also often seen in patients with
schizophrenia. (Snyder, 1971) and it has,

therefore, been as -

sumed to be partly due to an abnormal increased activity of
nigro-neostriatal dopamine neurons (Fuxe et al., 1970).
This view is substantiated by the fact that neuroleptics
which are potent antipsychotic drugs block dopaminergic
neurotransmission (Corrodi et al., 1971).
d.

Autonomic functions
The observation that dopamine increases cardiac out-

put and increases systemic blood pressure (Noyer et al.,
1971) suggest that dopaminergic neurons may play a role in
central vasomotor mechanism.

Since the administration of

dopaminergic blocking agents such as spiroperdal and pimozide decrease blood pressure (Fuxe et al., 1970).
e.

Sensory neglect following removal of the nigrostriatal
dopamine system
Three to four days after

~

unilateral removal of the

nigrostriatal system there is an almost complete lack of
orienting response to all sensory stimuli on the side contralateral to the J.esion, while the animal reacts in an es-
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sentially normal way to stimuli-to the side ipsilateral to
the lesion (Ungerstedt, 1973).

Simple reflexes like the

withdrawal reaction or the corneal reflex,
both side_s.

are normal on

The period from five days to two months after

the operation is characterized by partial recovery of sensory functions.
of the

anim~ls

Even two months after the operation none
show normal responses on the side contra-

lateral to the lesion.
first,

The sense of smell seems to recover

then vision and yet none of the animals regained a

normal reaction to touch (Ungerstedt, · 1973).
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B.

Adipsia and Aphagia After Degeneration ·Of the NigroStriatal Dopamine System
Detailed mapping of the central monoamine pathways

(Ungerstedt, 1971) show the dopamine axons to be located in
a dense bundle in the lateral hypo thalamus before entering
into the crus cerebri.

There is a vast literature in the

field of physiological psychology and especially in connection with consumatory behavior where the effects of lesions
and stimulations in this area are carefully studied.
ever,

How-

the dopamine system has received little or no atten-

tion, probably because detailed inf'orma tion of its anatomy
has been lacking.
A great deal has been learned concerning the changes
in food and water r egulation follo wing lateral h y pothalamic ·
lesions; little is known concerning the spe cific anatomical
structures or systems involved.

Several investigations

have suggested that the critical areas for producing the
lateral hypothalamic syndrome may be outside or include only a lateral segment of the lateral hypothalamus

(Morgane,

1961; Gold, 1967; Grossman and Grossman, 1971; Wampler,
1971).

Gold (1967) outlined a critical forebrain area for

producing aphagia and adipsia.
of the g1obus pallidus,
capsule.

This area included a portion

the medial portion of the internal

It is known that several fiber systems pass

through these three a reas which regulate the telancephalic
content of norepinephrine , dopamine and serotonin.

The

nigro-striatal bundle, a fiber system that regulates the
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dopamine content of the neostriatum, passes · through each of
the three areas described by Gold (1967).
_ Electrocoagulation in the lateral hypothalamus interrupting the axons of the nigro-striatal dopamine pathway
cause the dopamine terminals in the corpus striatum to degenerate thus resulting in a decrease in the dopamine content of the neostriatum (Poirier et al., 1967; Faull and
Laverty, 1969; Moore et al., 1971; Ungerstedt, 1971).

Symp-

toms of adipsia and aphagia appear after the lesions; since
other than dopamine neurons may have been destroyed the results may not be due to interruption of dopamine fibers
The technique of

alone.

int~ocerebral

injections of 6-hy-

droxydopamine permits a more selective degeneration ·of dopamine and noradrenergic pathways (Ungerstedt, 1971).

The

development of adipsia and aphagia was correlated to the
histochemical effects of the 6-hydroxydopamine lesions.
Adipsia and aphagia always followed a complete bilateral degeneration of the nigro-striatal dopamine system regardless
if the 6-hydroxydopamine was injected into the substantia
nigra,

the area ventralis tegmenti or the lateral hypothal-

amus (Ungerstedt, 1970, 1971).

However, where the ascending

noradrenergic pathways were lesioned no adipsia and aphagia
developed in spite of the fact that most of the hypothalamus degenerated (Ungerstedt, 1971).
~r~vious

reports,

In agreement with

intraventricular administration of 6-hy-

droxydopamine in monoamine oxidase inhibited · animals or bilateral injections of 6-hydroxydopamine into substantia nigra

- - -- ---- .......
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produced aphagia and adipsia (Fibiger ~al., 1973).

Oltsman

and Harvey (1972) found that electrolytic lesions of the lateral hypothalamus which destroyed the dopaminergic nigrostria tal tract produced severe aphagia and adipsia.
The adipsic and aphagic syndrome seen after nigro-striatal destruction is severe.
that i f not supported,
ter lesions.

-ungerstedt ( 1970, 1971) found

the animals died four to five days af-

Their condition was generally worse than that

which is seen where a normal animal is deprived of food and
water (Ungerstedt, 1971).

Oltsman and Harvey (1972) also re-

ported a severe aphagia and adipsia after nigro-striatal
lesioning.

Recovery of food and water intake is

re~orted

to

have occurred within ten days of intraventricular 6-hydroxydopamine (Zigmond and Stricker, 1972; Fibiger et al., 1973).
Nigral injections of 6-hydroxydopamine produce a more severe
effect with recovery failing to occur during a three month
period (Fibiger et al., 1973).

Animals with nigro-striatal

lesions show deficits in water regulation and food intake
as have been found in lateral hypothalamic lesioned animals
(Oltsman and Harvey, 1972; Fibiger et al., 1973; Marshall
and Teitbaum, 1973).

Rats with nigro-striatal destructions

progress through the same sequence of stages in the recovery
of feeding as do rats with lateral hypothalamic lesions
(Marshall and Teitelbaum, 1973).
Ungerstedt· (1970, 1971) has shown that adipsia and
aphagia is the result of a loss in striatal dopamine. Zigmond
and Stricker ( .1 972, 1973) have also found that depletion of
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brain dopamine was more critical for producing symptoms of
the lateral hypothalamic sundrome than was depletion of brain
norepinephrine.

Glick et al.,

(1974) have found lesion-in-

duced weight loss to be highly correlated with depletion of
striatal dopamine but not telencephalic norepinephrine.
rats with severe dopamine depletions,

In

the degree of weight

loss was related more to the striaturn with the highest remaining level of dopamine suggesting that a critical level of
doi:>amine in one striatum may be essential for lateral hypothalamic recovery.
r~ported

Zigmond and Stricker (1973) have also.

that residual brain catecholamines appear to make

a significant contribution to the recovery of ingestive behavior in rats with either 6-hydroxydopamine or electrolytic
lesions.

Rats after intraventricul a r

6-hydroxydopamine or

lateral hypothalamic lesions decrease food and water intake
markedly after the administration of methyl-para-tyrosine a t
doses that did not affect the ingestive behaviors df controlled rats (Zigmond and Stricker, 1973).

These results

suggest that recovery from aphagia and adipsia is dependent
upon compensatory processes occurring with the damaged systerns.

Severa.l mechanisms have been proposed which might

account for this compensation,

such as an increa.se in cate-

cholamine turnover in terminals of remaining fibers
et al.,

(Bloom

1969; Uretsky ~al., 1 9 71), an increased sensitivity

of postsynaptic receptors (Ungerstedt, 1971; Uretsky and
Schoenfeld, 1971; Schoenfeld and Uretsky, 1972), and sprouting of new terminals f rom transceted axons (Katzman~ al.,

..
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,

~.

1971; Nygren et al., 1971) •
Recently, various kinds of chemical treatments have
been found to attenuate the severity of the aphagia and adipsia following bilateral lesions of the lateral hypothalamus.
Recovery of feeding behavior has been facilitated by systemic
injections of either methyl-p-tyrosine or insulin for a few
days prior to surgery.

Rats with bilateral hypothalamic le-

sions die of starvation within seven days of surgery.

But

when these rats are pretreated with methyl-p-tyrosine they
spontaneously eat, drink and gain weight after surgery (Glick
et al., 1972).

These data suggest that recovery of func-

tions after lateral hypothalamic damage involves denervation
supersensitivity since, methyl-p-tyrosine should have pharmacologically produced a partial
serving recovery.

denervatio~

of neurons sub-

Glick and Greenstein (1972) have also

suggested that recovery from lateral hypothalamic lesions
may involve the sprouting of intact inputs to the remaining
lateral hypothalamic noradrenergic neurons.

They found that

if frontal cortical lesions were produced thirty days prior
to lateral hypothalamic lesioning recovery was facilitated.
The period of recovery after bilateral electrolytic lesions
of the lateral hypothalamus is shortened if insulin is given
for five days before surgery (Balagura et al., 1973).

Re-

covery of feeding has also been facilitated when rats are
reduced by food deprivation to seventy-five per cent of their
normal body weight.

This food deprivation facilitated re-

covery has been shown for lateral hypothalamic lesions

2J

(Powley-Keesey, 1970) and 6-hydroxydopamine treatment (Myers
and Martin, l97J).
Enhanced recovery of feeding after hypothalamic damage
.has been reported

~n

response to an intraventricular injec-

tion of nerve growth factor (Berger et aJ_., 1973).

These

authors speculate that nerve growth factor may facilitate
behavj_oral recovery by promoting the development of supersensi tivity to norepinephrine and possibly also by stimulating the growth of regenerating noradrenergic neurons in the
brain.

Postoperative alpha-methyl-para-tyrosine treatment

has been sho>vn to facili:tate survival but the dose of alphamethyl-para-tyro sine which will produce this effect ;_s
critical (Glick and Greenstein, 1974).

Initially, alpha-

methyl-para-tyrosine improved feeding mechanisms involving
catecholamine and thereby promoted the development of denervation supersensitivity which became behaviorally manifested after the effect of alpha-methyl-para-tyrosine on
catecho lam ine synthesis had subsided (Glick and Greenstein,

1974).

Electrical stimulation through the same electrodes

that induced aphagia by means of a mechanical lesion has been
shown to shorten the post lesion recovery period (Harrell
et al •. ,

1974).

Alte ration of the esculent property of the

diet given f'ollow ing lateral hypothalamic lesioning has also
been shown. to e f:t·ect recovery from the syndrorne (Myers and
Martin,

1973).

Recovery of a postoperative weight loss fol-

lowing bilateral ablations of frontal cortex in rats is
quicker when food pellets are scattered on the cage floor
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than when pellets were available only in attached food hoppers (Glick and Greenstein,

197J).

The period of recovery

after bilateral electrolytic lesions of the lateral hypothalamus in r ats is lengthened if gluc agon is given during
the preoperative period (Balagura et a l., 197J).

Bilateral

lesions made in the habenular nuclei had little effect on
recovery of feeding following lateral hypothalamic lesions
(Mok et ·al., 1973), thus suggesting that the habenular
nucleus is not a crucial part of the feeding syst.em which
mediates the recovery from the lateral hypothalamic syndrome.
C.

Cortical Dopaminergic Terminals
For a number of years it had been generally assumed

that all catecholaminergic cortical nerve terminals were
nor-adrenergic.

However, high concentrations of dopamine

have been found in the cortex of various species (Bertler
and Rosengren, 1959; Valzelli and Garatlini, 1968).

It ap-

pears that most of the dopamine found in the cortex of the
rat is not localized in nor-adr e nerg ic terminals.

Lesions

of the dorsal nor-adrenergic system or a combined lesion
of the dorsal and the ventral nor-adrenergic systems, which
both significantly decrease the cortical levels of norepinephrine, did not induce a parallel reduction in cortical
dopamine content (Thierry!:..!. al., 197Jb).

These findings

strongly suggest the existence of dopaminergic neurons in
the cortex.

Further evidence for the e xistence of dopa-

minergic terminals in the rat cortex is taken from the fact

that cortical synaptosomes have the ability to synthesize
JR-dopamine from JR-tyrosine (Thierry

t l al., 197Ja).

The destruction of ascending noradrenergic pathways which
abolishes the in vitro synthesis of JR-norepinephrine did
not abolish the synthesis of JR-dopamine (Thierry et al.,
197Ja).

Also,

a specific dopamine reuptake process has

been demonstrated in the cerebrc'fl ·cortex of normal rats
and rats whose ascending noradrenergic pathways have been
selectively destroyed (Tassin et al., 1974).

Visualiza-

tion of these dopaminergic terminals has been achieved by
combined pharmacological and histochemical methods
(Lidbrink

t l al., 1974).

The occurrence of dopaminergic

nerve endings was further

~upported

by the demonstration

of a dopaminergic receptor in the cortex.

Specifically,

dopamine was found to activate an adenylate cyclase systern and this effect was inhibited by the dopamine receptors blocker haloperidol {van Rungen and Roberts, 197J).
D.

Recovery Mechanism Within the Central Nervous System
Recovery from central nervous system lesions appears

to be dependent on compensatory processes occurring within the damaged system.

Several mechanisms have been pro-

posed which might account for this compensation;

such as

an increase in catecholamine turnover in terminals of remaining fibers,

an increase in sensitivity of postsynaptic

receptors and sprouting of new terminals from transected
axons.
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1)

Catecholamine Turnover
Reduced accumulation of intraventricularly adminis-

tered 3H-l-norepinephrine was seen in the brain of rats
who were treated with intraventricular injections of 6hydroxydopamine.

The loss of catecholamine uptake sites

produced by the 6-hydroxydopamine pretreatment was probably responsible for the reduction in accumulation
(Uretsky et al., 1971) • . The rate constant of disappearance of 3 H-norepinephrine was used to estimate the fraction of the endogenous norepinephrine pool turning over
per unit of time.

An increase in the rate constant in

the pons-medulla region was seen in 6-hydroxydopamine
treateci·rats.

An increase in the rate constant may indi-

cate that norepinephrine containing neurons which survive
the degeneration effects of 6-hydroxydopamine show an
increase in their physiological state of activity to compensa t e for the loss of neuronal function after degeneration ( Uretsky ~al., 1971). Alternatively,

the nor-

adrenergic neurons which have a higher turnover than average may

survive the effects of 6-hydroxydopamine.

Since

6-hydroxydopamine causes a profound and long-lasting depletion of norepinephrine in all . brain r e gions . (Uretsky
and Ive rsen, 1 97 0),

the t urnover rat e of norepinephrine in

6-hydroxydopamine pretreated animals was much lower than
in cont rol brains despite the increase in rate constant
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observed in the pons-medulla (Uretsky .£.!.al., l97l).
results are consistent with those of' Bloom et al.

These

(1969),

who found a decrease in the turnover of norepinephrine in
whole brain of 6-hydroxydopamine treated rats.

In these

experiments there was an increase in the rate constant in
the striatum;

this reflects the disappearance of 3 H-no-

repinephrine from mainly dopaminergic neurons.

This in -

crease in the rate constant may nevertheless reflect some
compensatory change in the level of activity of the surviving dopamine-containing neurons.
A marked increase in dopamine specific activity has
been found after intravenous administration of 3 H-tyrosine
in animals following injections of 6-hydroxydopamine in to
the substantia nigra.

Furthermore,

these lesioned animals

showed enhancement of the 3 H-H 0/DA rg_tio on the lesioned
2
side following injections of the radioactive precursor.
An increase in the ratio of homovanillic acid to the dop-

amine content in the striatum on the side lesioned with
6-hydroxydopamine has also been found (Agid et al., 1974).
These results indicate

a

hyperactivity of the remaining

dopaminergic neurons following partial degeneration of
the nigrostriatal pathway.
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2)

Postjunctional Supersensitivity
Supersensitivity may be defined as the phenomenon in

which the amount of a substance required to produce a given
biological response is less than normal.

Thus,

the one

consistent sign of supersensitivity is a shift in the maximum response to a drug (Fleming et al., 1973).

An apparent

change in sensitivity of the postjunctional element to nerve
impulses could result from any one of several changes in
the transmission apparatus.

There could be a change in the

postjunctional element so that it actually became more sensitive to the transmitter (Thesleff, 1960).

The mechanism

inactivating the transmitter could change so that it is removed from its site of action more slowly (Trendelenburg,

1963).

Prejunctional elements could increase their capacity

to deliver transmitter or change their recovery process to
repetitive stimulation (Sharpless, 1969).

Many of these

changes are known to occur in disused or denervated peripheral structures.
There is evidence that spinal motor neurons become
more reactive to a variety of stimuli following cord section
(Cannon and Rosenblueth, 1949; Stavraky, 1961), and destruction of sensory nerve fibers

(Cannon · and Rosenblueth, 1949;

Stavraky, 1961; Loeser and Ward, 1967).

Several weeks after

a tenotomy, which relieves tension on muscle spindles and
thus reduces the activity of Group la sensory fibers, monosynaptic discharge elicited by stimulating Group la fibers
had greatly increased j_n strength (Beranek and Hnik, 1959;
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Kozak and Westerman, 1961).
Supersensitivity of the temperature regulating center
of the hypothalamus has been shown to develop in response
to chronic administration of scopola~ine (Friedman and
Jaffe ·, 1969; Friedman et al., 1969).

When scopolamine was

administered to mice for various periods ranging from five
days to four weeks and then withdrawn,

an exaggerated hypo-

thermic response to pilocarpine and other centrally acting
cholinergic drugs was seen.

Sharpless and Halpern (1962)

found that in the isolated cerebral cortex of the cat supersensitivity emerged in two to three weeks after surgical
denervation.

Supersensitivity to metamphetamine has been

shown to occur after treatment with alpha-methyl-para-tyrosine (Paschel and Nintemon, 1966).
Following intraventricular administration of 6-hydroxy-dopamine which destroys catecholamine containing nerve
terminals, L-dihydroxy-phenylalanine (dopa) produces a
marked increase in the locomotor activity of treated rats,
while it has little effect on the activity of untreated rats
(Uretsky and Schoenfeld, 1971).

These results suggest the

enhanced effects of L-dopa may be due to a central supersensitivity to catecholamine.

The behavtoral response to

apomorphine is altered by 6-hydroxydopamine pretreatment
while lowering the ED
Uretsky, 1972).

50

for apomorphine (Schoenfeld and

A modified response to apomorphine,

ad-

ministered directly into the striatum has also been reported
in reserpine-treated rats (Fuxe and Ungerstedt, 1970).
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Jalfre and Haefely (1971) have reported that 6-hydroxydopamine treated rat.s s howed increased motor activity after low
doses of apomorphine which were inefr ective in normal animals.

A shift i n the dose-response curve in the direction

of increased sens itivity was found in response to apomorphine after withdrawal of chronically administered reserpine,
alpha-methyl-para-tyrosi.ne or chlorpromazine (Tarsy and
Baldessarini, l97J).

Chronic administration of haloperidol

has been shown to result in a supersensitivity of dopamine
receptors ..

This supersensitivity is manifested by an en-

hanced stereotypy and aggression in response to small, otherwise ineffective doses of apomorphine (Gianutsos et al.,
1974).

Apomorphine has been shown to effectively decrease

turnover of dopamine in haloperidol treated rats at doses
which were without effect in drug-naive rats (Gianutsos et
al. , 1971+) •
Chronic den ervation of the rat pineal gland leads to
an increase in the cyclic AMP response to norepinephrine
within three weeks (Weiss and Costa, 1967).

Pineal denerva-

tion has been shown to also induce supersensitivity in the
postsynaptic beta adrenergic receptor site on the pineal
cell to catecholamines.

Elevation of adenosine cyclic 3',

5' monophosphate was also seen in response to denervation
and this resulted in the superinduction of N-acetyl-transferase in the p i neal gland (Deguchi and Axelrod, 1973).
responsiveness of the pineal beta adrenergic receptor has
been found to cha nge sensitivity,

in response to diurnal

The

Jl

changes (Rom~ro and _.<\xelrod,

l974).

An increase in the cy-

clic AMP response to norepinephrine has been found to occur·
in the hypothalamus, cerebrum and brainstem of rats treated
seven days beforehand with 6-hydroxy-dopamine (Palmer,
Prior to destruction of the dopamin~rgic innerva-

l972).

tion in the striqtum by 6-hydroxydopamine or chronic inhibition of dopamine synthesis by alpha-methyl-para-tyrosine
fails to alter dopamine stimulated cyclic AMP formation.
These results indicate that dopamine sensitive adenyl c·yclase
does not

ap~ear

to increase during dopaminergic denervation

supersensitivity (Von Voigtlander et al.,

l97J).

A model proposed for physical dependence and associated tolerance is what Emmlin (l961) called the supersensi--tivity 0£ pharmacological denervation.

According to the

disuse theory of physical dependence, presence of the drug
entity is only indirectly responsible for the development of
dependence;

the direct or proximal cause is depression of

nervous activity for long periods of time (Sharpless,

1969).

Withdrawal phenomena generally seem to represent rebound
effects, opposite in character to those produced by the drug
itself, as i f depressed pathways· become hyperexcitable dur ing withdrawal and stimulated pathways become - depressed
(Sharple~s,

1969).

Sharpless and Halpern (1962) suggest

that supersensitivity of receptors might underly the convulsions resulting from withdrawal of barbituates after the induction of physical dependence.

It has also been suggested

to account for physical dependence and tolerance towards
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morphine (Jaffee, 1965; Collier, 1966).

The effectiveness

of apomorphine and amphetamine in enhancing morphine withdrawal aggression when given in otherwise ineffective doses
has led Lal and co-workers to suggest receptor supersensitivi ty during narcotic dependence (Lal et al., 1971; Lal and
Puri, 1972; Puri and . Lal, l97J).

3)

Evidence for Regeneration Axon Sprouting of Central Catecholamine Neurons
For many years a general conclusion of neurohistologi-

cal investigators was that adult manunal cerebral nerve fibers show only feeble and abortive regenerative growth when
sev~red

(Cajal, 1928; Clark, l94J).

ported sprouting from cut central

Thus, many have reaxons, but this process

soon terminated and the newly formed axons sprouts were described as degenerating within a few weeks.

There is now

d a ta to suggest the brain may be capable of some plastic
modifications in response to deafferenting lesions; there
is now evidence for more persistent a nd functional regeneration.
It is well known that upon severing or traumatizing
a monoamine nerve axon or an axon collateral,

the trans-

mitter accumulates within the axon itself (Dahlstrom and ·
Fuxe, 1964; Dahlstrom, 1965).

In fact,

it is this phenome-

non that has permitted the mapping out of catecholamine-containing fibers tracts in the central nervous system.

The

intraaxonal catecholamines accumulate very rapidly after
the injury and remain approximately twelve days after which
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they gradually disappear (Dahlstrom and Fuxe, 1965).

During

the seventh to nineteenth days after electrolytic lesions
in the mesencephalon of the
delicate,

r~t

a type of densely packed,

fl .uorescent, vancose fiber become visible in the

vicinity of the axonal accumulations (Katzman et al., 1971).
This increase is ascribed to _regeneratio:h or sprouting of
catecholamine fibe~s ~t the border of the l~sion.

Although

the catecholamine fluorescence in this fiber on the border
of the lesion had decreased at seven weeks,

the normal cate-

cholamine concentration in the preterminal part of the axon
is too low to be visualized with the histochemical method
(Ke.tzman et al., 1971).

--

These newly formed fibers could ei-

ther represent the growth of the central catecholamine neurons, whose axons have been cut by the lesion, or sprouting
from the intact axons passing near the lesion.

Studies em-

ploying lesions in the rat spinal cord show the development
and growth of newly formed fiber sprouts from severed axons
(Katzman et al •. , 1971; Bjorklund et al . , 1971).

Reinnerva-

tion of the distal part of the spinal cord by new noradrenergic fibers following 6-hydroxydopamine denervation has
been shown (Nygren et al., 1971).
buted to resrilt from

Reinnervation was attri-

outgrowth of axotomized fibers,

but

growth in the form of collaterals . sprouting from a few
possibly surviving fibers in the distal region may be invalved.

A normal pattern of innervation was seen within

one to two months after denervation (Nygren et al., 1971).
After a unilateral entorhinal lesion (a major extrin-

sic afferent to the hippocampal formation),

a new fiber pro-

jection from the remaining contralateral entorhinial cortex
grows to reinnervate the dentate gyrus.

These new fibers

establish electrophysiologically functional synaptic connections with the denervated dentate granule cells (steward et
al.,

1974).

These results indicate that reinnervation has

functional significance and that the reinnervating fibers
may be functionally homologous to those which were destroyed
by the lesions.

The manner of .reinnervation by contralater-

al entorhinal fibers also suggest that the growing fibers
are guided to the denervated site (steward et al., 1974).
Col.1_ateral reinnervation has l;>een shown after partial deafferentation of the septal nuclei.

It is a predictable phe-

nomenon, which follows a rigid time course and results in a
characteristic pattern of synapse formation (Raisrnan and
Field,

1973).

Abundant growth of nerve fibers into and

across thin laminar lesions of the rabbit cortex have been
reported by Rose et al.

(1960).

Another case of significant

neuronal regeneration has been reported in the hypothalamohypophys ial
ferret

tract after pituitary stalk transection in the

(1968).

Lesioned central catecholamine neurons in

the rostral mesencephalon show a considerable

capac~ty

for

growth into smooth muscle transplants and into and along
the walls of cerebral blood vessels (Bjorklund and Stenevi,

1971).
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E.

Morphine and Brain Dopamine
The relationship between neurotransmitters in the brain

and the pharmacological activity of narcotic analgesics has
received considerable attention in the last several years.
S~rotonin,

acetylcholine, norepinephrine and dopamine are

among the neurotransmitters that have been implicated in the
effect of morphine.

l)

Acute Effects of Morphine
Morphine in a dose of 20 mg/kg has been shown to cause

a thirty-two per cent decrease in mouse brain dopamine and
twenty-three per cent decrease in norepinephrine when assayed fluorometrically. The time course of this effect on
dopamine is seen to correspond to analgesia produced by morphine (Takagi et al., 1966).

The acute adininistration of

morphine has been shown by others to cause a similar decrease
of brain dopamine as well as norepinephrine in mice (Reis
et al., 1969; Rethy et al., 1971.).

In rats,

there was no

difference in the brain dopamine levels one hour after an
acute dose of morphine (Gunne et al., 1969; Wantanabe et al.,

1969; Johnson and Clouet, 1973; Puri et al., 1973}.
ever,

a

How-

transient increase in dopamine levels at two and

four hours after morphine has been reported (Johnson and
Clouet, 197 3).
The conversion of

14 .

C-tyrosine in vivo into

14

C-c·ate-

cholamines has been shown to increase after the acute administration of either morphine or levorphenol (Smith et
l

~.,

·
d incorpora
·
t·ion o· f 14 c - t yrosine
·
1970 , ·197 2 ) • The increase
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in o
C-catecholamine was seen in the whol.e brain of mice
after JO mg/kg or 100 Iµg/kg of morphine (Smith~ al., 1970,
Morphine was found to increase the synthesis of

1972).

catecholamines ·in the cerebral cortex, diencephalon,
aturn, brainstem and cerebellwn.

Naloxone,

stri.-

a narcotic antag-

onist, blocked the effects of morphine upon the incorporation
of

14

c-tyrosine into

14

c-catecholamines.

Tolerance has been

shown to occur to this effect of morphine (Smith~ al.,
1972).

Clouet and Ratner (1970) found that acute morphine

administration increased the accumulation of
when

14

c-tyrosine was injected cisternally.

14

c-dopamine,

A maximum in-

crease was reached in the striatum and hypothalamus one hour
after morphine administration.

Enhanced accwnulation of JH-

dopamine was seen after the i.v. administration of C-J,5-Htyrosine in rats treated with morphine.

Increased accwnula-

tion of 3H-dopamine and 3H-H 0 was seen in tissue and mediwn
2
of striatal slices incubated with 3 H-tyrosine in response to
morphine treatment (Gauchy et al., 1973).

These results in-

dicate that morphine stimulated dopamine synthesis.

In-

creased release of newly synthesized JH-dopamine was also
seen which was evidenced by a greater accwnulation of JHdopamine in incubating mediwn of slices of morphine pretreated rats (Gauchy ~al., 1973).

Similar results of in-

crease in the synthesis of dopamine and reversal by naloxone
were also observed by Loh et al.

(1973).

Another pharmacological approach to study catecholamine turnover is the use of a catecholamine synthesis in-

3,7

hibitor, alpha-methyl-para-tyrosine.

Acute administration

of morphine has been found to cause an accelerated depletion
of brain dopamine after catecholamine synthesis

inhibi"tion~

This effect is interpreted as an increased activity within
the ascending dopamine neuron system (Gunne et al., 1969).
Similarly, Puri et al .

(1973) · have sho·wn °a faster depletion

of striatal dopamine by morphine in methyl-para-tyrosine
treated rats,

suggesting an increased dopamine turnover.

Kuschinsky (1973) has also shown morphine to significantly
increase the depleting effect of methyl-para-tyrosine.
In rats,

the catalepsy induced by analgesic doses of

morphine has been shown to parallel a dose-dependent increase in the concentrations of homovanillic acid,
mine metabolite,

in the striatum (Kuschinsky

1974 and Ahtee et al., 1973).

a dopa-

t l al., 1972,

In the who le mouse brain

Fukui and Tukagi ·(1972) have found a significant rise in
the dopamine metabolites, homovanillic. acid and J,4-dihydroxyphenyl acetic acid, with analgesic doses of morphine.
This increase in homovanillic acid is explained by an increased dopamine turnover,

thus a rise in dopamine utiliza-

tion in the striata (Kuschinsky, 1973 and Kuschinsky et al. ,
1974).

The catalepsy and the ri$e in striatal homoyanillic

acid concentrations produced by morphine were inhibited by

--

naloxone (Kuschinsky et al.; 1972) a morphine antagonist,
whereas the corresponding effects of chlorpromazine were
not influenced by the nalaxone.

Morphine had an additional

effect on striatal homovanillic acid increase when combined

J8

with a maximally effective dose of chlorpromazine (Kuschinsky
et al.,

1974).

These results are interpreted to suggest that

i t is unlikely that morphine excited its effects on homovanillic acid in a manner like chlorpromazine {Kuschinsky e t
al.

1974).

They conclude that the main site of morphine's

- action may be presynaptic, where the drug might interfere
directly or indirectly with the metabolism of dopamine at
the corresponding terminals.
On the basis of their studies with methadone,
et al.

Sasame

(1972) have postulated that the cataleptic effect

and the increase of dopamine utilization,
ic analgesics,

induced by narcot-

are due to a postsynaptic dopamine receptor

blocking effect.

Puri et ~·

{1973) have also

a postsynaptic blocking effect of morphine.

argu~d for

They have shm.,n

that morphine treatment blocked stereotYPed behavior in rats
induced by amphetamine or apomorphine which are due to stimulation of dopamine receptors.

Further evidence that mor-

phine acts as a dopaminergic receptor blocker comes from
the stud y of asynunetrics and turning produced in rats after
unilateral removal of the caudate nucleus or lesioning of
the nigro-striatal dopamine neurons.

Morphine in a dose of

· 2 mg/kg caused asymmetry to the operated side,

as did halo-

peridol (5 mg/kg ) a known dopaminergic blocking agent (Fu.xe
and Ungerstedt,

1970).

This data along with the blockade by

morphine of amphetamine and apomorphine induced stereotyped
behavior {Fu.xe and Ungerstedt,

197.0 ; Puri t l al., 1973) sup-

port the view that morphine acutely acts as a dopamine
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receptor blocker.

Such a blockade can explain the. increased

t .u rnover found in the ascending dopamine neurons after morphine (Gunne ~al., 1969; Puri et al., 1973).

The blockade

of dopamine receptors could induce a compensatory nervous
feedback onto the presynaptic dopamine cell bodies in the
mesencephalon.

This will result in an increased nervous im-

pulse flow in dopamine neurons, which would result in increased dopamine turnover (Fuxe and Ungerstedt, 1970).
The intehsity of the catecholamine fluorescence measured in nerve cells of substantia nj_gra, ventromedial tegmental area, and midbrain reticular formation by a modification of the histochemical method of Falck and Hillorp showed
increased intensity in the male mouse in response to 40 mg/
kg of morphine (Heihrich et a l.,

1971).

In female rats on-

ly the cells of the substantia nigra showed a rise in
fluorescence intensity after 20 mg/kg of morphine (Heinrich
et al., 1971).

Gunne et al.

(1 969) have shown that acute

morphine plus methyl-para-tyrosine produced an increased depletion of fluorescence from the dopamine terminals in the
nucleus caudatus putamen, nucleus accumbens and terberculum
olfactorium.

No change in the degree of depletion in vari-

ous noradrenergic terminals systems was seen after methylpara-tyrosine (Gunne

!:.!

al., 1 969).

This change in fluo-

rescence appears to be due to an enhancement of amine synthesis.
Subanalgetic levels of morphine have been shown to
produce mixed inhibitions of dopamine transport into slices
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from the mouse brain cortex and uncompetitive inhibition in
the diencephalon.

Increased concentrations of morphine pro-

duced a greater effect on dopamine affinity rather than reaction velocity which was observed in the cortex although
inhibition remained mixed.

In the diencephalon the type of

inhibition changed from uncompetitive to mixed kinetics
(Hitzemann et al.,

iue up t a k e o f

1973).

mi...

· ·
ra't· s t riaturn
synap t osomes an d o f

14 c - d opamine
·
·

14 c -norepinep
· ·
h rine
·

· t o
in

· t o
in

hypothalamic synaptosomes was inhibited by morphine in concent rations of 10

-5

and 10

.,.6

M,

respectively.

Kinectic

analyses of dopamine uptake in the presence of morphine suggest that low affinity uptake was inhibited rather than high
affinity uptake (Clouet et al.,

1974).

The in vitro and 1:E_ vivo activity of tyrosine hydroxylase after the administration of morphine has been studied by
·
measuring the conversion
of

cholamines (Fuxe et al.,

14

c - t yrosine
·

t o Do PA an d

ca t e-

1972; Lok et al., 1973).

Morphine did not modify the activity of tyrosine hydroxylase in brain homogenates.

In vivo experiments show a

significant increase in brain tyrosine hydroxylase activity
after morphine.

The authors suggest that an acceleration

of dopamine biosynthesis may be due to the activation of
feedback mechanism in vivo.

----

Furthermore, a significant in-

crease in the specific activity of brain tyrosine was observed after morphine, by other investigators and they also
found this effect was blocked by the morphine antagonist,
naloxone (Loh et al.,

1973).
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2)

Effects of Chronic Morphine
Gunne (1963) noted no change in dopamine content in

the telencephalon of dogs treated daily for seventy to

nine~

ty days with increasing doses of morphine up to 120 mg/kg~
Dopamine was also found unchanged in various brain regions
of the morphine dependent monkey (Segal~ al., 1962; Segal.
- et al., 1972).

During chronic administration of morphine
disappear~d

its effect on brain dopamine

and the impulse flow

became . normal within ascending dopamine neurons system
(Gunne et al., 1969). --- In rats,

there was a slight increase

in the brain levels_ of dopamine after chronic administration _
of morphine (Sloan et al., 1963; Johnson and Clouet, 1973).
The increase in brain dopamine concentrations was suggested
to be attributed to the increase in the syni;besis of dopamine after chronic administration of morphine (Clouet and
Ratner, 1970; Johnson and Clouet, 1973).

The incr-ease in

dopamine synthesis was suggested to be associated with the
increase in tyrosine hydroxylase activityafter chronic mor-·
phine (Reis~ al.,
Smith et ~·

1970).

Contrary to these findings

(1972) have shmm. that after repeated adminis-

tration of either morphine or levorphenol tolerance and
cross tolerance developed to the effect of these drugs upon
th e syn t hesis o f

14

c -dopamine
·

an d

14

c -norepinep
·
h rine.
·

It

is interesting to note that the excretion of dopamine was
reported to be increased in rats (Sloan and Eisen.men, 1968)
and male human volunteers (Weil-Malberbe ~al., 1965) ·during the addiction phase.
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3)

Effect of Morphine Withdrawal
Gunne (1963) reported that brain dopamine was decreased

seventy-two hours after morphine withdrawal.
dogs exhibited moderate to severe abstinence.

At this period
Maynert and

Klingman (1962) observed similar findings during withdrawa l
in dogs and rabbits but observed no change in brain dopamine
on rats during withdrawal from morphine.

Abrupt withdrawal

has been shown to reduce activity in the brain dopamine neurons.

Histochemical results showed that methyl-para-tyro-

sine did not cause any effect within the dopamine or noradrenergic neurons that could be distingui.shed from the
effect of synthesis inhibition alone.

Nalorphine-injuced

abstinence caused increased activity within the noradrenaline neuron system in practically all parts of the brain
(Gunne et al.,

1969).

Contrary to this study a transient

increase in dopamine levels was reported in rats and mice
after naloxone induced withdrawa l

(Iwamoto~ al.,

1973),

which is suggested to be responsible for the stereotyped
jumping in mice and rats during withdrawal.

In rats, brain

dopamine and norepinephrine levels decreased during withdrawal from morphine when compared with chronic morphine
levels (Sloan et al., 1973).

The striatal dopamine turn-

over in morphine dependent animals was shown not to differ
from the turnover in non-dependent animals when measured
one,

twenty-four and seventy-two hours after the last mor-

phine injection (Puri, 1973).

Also,

dopamine levels were

4'.3

replenished at a more rapid rate during morphine withdrawal
after the administration of reserpine (Gunne et al., 1970).
The urinary excretion of dopamine in rats was increased during withdrawal with peaks occurring on the third
and eighth day (Sloan and Eiseman, 1968).

In humans, how-

ever, ·the urinary excretion of dopamine was found to be decreased during the withdrawal phase (Weil-Malherbe .£.!_al.,

1965).
Upon withdrawal from morphine, aggregation of the dependent rats elicited intense aggression.
the withdrawn rats with L-dopa,

amphetamine or apomorphine

before aggregation enhanced the aggressive
fold.

Haloperidol,

Pretreatment of

response~

several-

a dopaminergic blocking agent, blocked

the aggressive behavior (Lal et al.,

1971; Puri et al.,

1971; Lal and Puri, 1972; Puri and Lal, 1973; Gianutsos
et al., 1974).

These data are interpreted to suggest a

dopaminergic basis ()f morphine withdrawal aggression and
the development of a latent supersensitivity of dopaminergic neuropathways during morphine dependence.
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F.

Apomorphine and Brain Dopamine
In both the central nervous system and in the periphery,

apomorphine is believed to stimulate the dopaminergic receptors (Anden et al., 1967; Ernst, 1967).

Biochemical studies

have shown that apomorphine decreases the turnover rate of
striatal dopamine.

The incorporation of C-14 tyrosine into

dopamine was found to be decreased after the administration
of apomorphine (Persson,

J.970; Nyback et al.,

1970).

Apo-

morphine also decreases the disappearance of dopamine after
alpha-methyl-para-tyrosine (Anden ~al., 1967; Anden and
Bedard, 1971; Puri~ al.,
decrease in the rate of

l97J).

form~tion

{Roos, 1965, 1969; Lahti et al.,

Similarly,

there was a

of homovanillic acid
1972).

The administration

of apornorphine can also result in the decreased accumulation of dopa after the administration of NSD 1025 (Koe,
1973).

The biochemical changes of brain dopamine produced

by apomorphine were completely blocked by haloperidol (Anden
et al., 1967; Persson, 1970; Anden and Bedard, 1971; Lahti
et a 1 • , 19 7 2 ; Puri et a 1 • ,

l 97J ) •

Apomorphine has also

been shown to inhibit tyrosine hydroxylase activity directly, but only in higher.doses than those necessary to induce
the functional changes (Goldstein~ al., 1970).
Single unit recording from dopaminergic areas has
made it possible to test further and investigate the effect
of apomorphine.

Apomorphine given intravenously in a dose

of 0.1 mg/kg has been shown to inhibit dopamine unit activity (Bunney ~ !3-1., l97J).

This effect is not influenced by .
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alpha-methyl-para-tyrosine but is blocked by haloperidol.
It is therefore possible to explain a decrease in synthesis
and turnover of dopamine by the concept of a

compensatory

neuronal feedback mechanism {Anden et al., 1969; Carlsson
and Linquist, 1973).

The interruption of' impulse flow .in

dopamine neurons cause a marked increase in striatal dopamine {Walters et al., 1973) an effect that can be blocked
by apomorphine {Anden ~ al.,1973).

This finding suggests

that dopamine neurons are at least partly autoregulatory.
Released or extraneuronal dopamine seems to act on presynaptic inhibitory dopamine receptors.

Stimulation of the in-

hibitory dopamine receptors on dopamine neurons,

either by

dopamine or apomorphine, may inhibit both nerve activity
and dopamine synthesis (Christiansen and Squire~,

1974).

The systemic administration of apomorphine produces
stereotyped behavior in rats which is characterized by continuous and compulsive sniffing,
1965).

licking and gnawing {Ernst,

The results of several studies have supported the

hypothesis that stereotyped behavior induced by apomorphine
is due to increased dopamine receptor activity {Ernst, 1969;
Fuxe and 'Ungerstedt, 1969).

Apomorphine has been shown to

produce hypothemia in mice.

This hypothemic effect is an-

tagonized by haloperidol and pimozide, indicating that
dopaminergic mechanisms are involved in temperature control
{Fuxe and Sjoqrist, 1972).

In a number of rats apomorphine

consistently facilitated sel f - st imulation but inhibited
this behavior in others {Broekkamp and van Rossum, 1974).

These results indicate that apornorphine is able to replace
the reinforcing action of intracranial rewarding stimulation.
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G.

Neuroanatomical Pathways Related to Morphine Dependence
and Abstinence
Physical dependence on morphine is characterized by

the appearance of abstinence signs when morphine intake is
abruptly terminated or when an opioid antagonist is administered.

The specific action of morphine and its surrogat·es

on the central nervous system suggest the presence of

neuro~

anatomical pathways which are selectively sensitive to opoid
compounds.
The neuroanatomical sites of morphine action have been
the subject of many investigations.

Lotti et al.

(1965)

demonstrated that the hypothnrmic effect of morphi.ne could
be induced when morphine was applied locally to the anterior hypothalainus.

Injection of' 50 ug of morphine sulfate in

to the region of the preoptic anterior hypothalamic nuclei
led to a fall in core temperature while injections into
other regions of the hypothalamus were ineffective.

Intro-

duction of the drug into the area of the mammallary nuclei
caused hyperactivity and hyperthermia.

It was suggested

that the hypothermic effect -of morphine is due to a depression of the set point of the hypothalamic thermostat,
possibly by rendering the cells insensitive to the stimulus
of the input from the cold receptors in the skin.

Tsou

and Jang (1964) also using the technique of intracerebral
microinjections,

localized the site of the analgesic ac-

tion of morphine in the rabbit to the periventricular gray
of the third ventricle.

Analgesia has also been reported
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by Herz et al.

(1970) after application onto the surface of

the fourth ventricle and Buxbaum

t l al. (1970) after appli-

cation into the anterior nuclei of the rat thalamus.

Nalox-

one has been found to reverse morphine analgesia in the
medial thalomic nuclei and in medial portions of the midbrain (Collins

t l al.·, 1974).

These results tend to indi-

cate that medial mesodiencephalic areas of the brain are invalved in morphine analgesia.

The caudate nuclei has also

been implicated as important in mediating the altered reaction to pain induced by morphine (Glick, 1974).

Bilateral

lesions of the caudate nuclei were shown to produce a persistent potentiation if the effect of morphine on
luten_cies (Glick, 1974).

~scape

These studies indicate that al-

though the opioid molecule may act on a common biochemical
element in different tissues,

the amount and the coupling

of the biochemical element of specific tissue functions determine the specificity of opioid actions.
The central sites related to physical dependence have
been studied by localized manipulations of brain tissue.
Wikler (1948, 1952) reported that removal of the cortex in
dogs did not attenuate the abstinence syndrome but that
spinal cord sections interfered with some withdrawal signs.
This work has been confirmed by the demonstration that morphine dependence has a supraspinal and spinal component
(Martin and Eades, 1964). It has been reported that bilateral rostral cingulomotomy markedly attenuates abstinence phenomena after withdrawal of morphine in monkeys and a variety
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of opioid analgesis in patients with intractable pain. Foltz

1957; Wilker (1972) has reported that the salutary

et al.,

effects of cingulumotomy on the morphine withdrawal syndrome consist largely of attenuation of non-specific (emotional) reaction to the unmodified specific morphine withdrawal syndrome.

Bilateral lesions in the cingulum, the

dorsalmedial thalamic nucleus,

the anterior temporal lobe,

or the septum do not alter the specific signs of the pri-

1972).

mary morphine withdrawal syndrome in the rat (Wilker;

No r do . cingulumotomy or lesion in the dorsomedial thalamic
nucleus,

the anterior temporal lobe or the septum prevent

relapse (Wilker,

1972).

Stereotaxic lesions in the

~entro-

medial nucleus suppressed or diminished the autonomic signs
of withdrawal and produced a marked intolerance to morphine

.

..

(Kerr and Pozuelo,

1971}.

Subsequent studies carried out

in monkeys showed that lesions of the hypothalamus,
d a la and septal nuclei,

amyg-

even if the tolerance for morphine

and severity of the withdrawal had been modified the lesion
had little or no effect on the craving for morphine,

as the

animals continued self-injected approximately the same
amount of' morphine sulfate as they did before receiving
their lesion (Kerr and Pozuelo,

1971).

Lesions placed

sterotaxically in monkeys in the organs of the nigro-striatal system and the nucleus tegementi ventralis, known to
be mainly dopaminergic pathways, · abolish craving for marphine and the phenomena of withdrawal, as evidneced, respectively, by lack of bar pressing and by absence of the
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manifestations of withdrawal (Pozuelo and Kerr, 1972).

Fur-

ther evidence for the involvement of dopamine pathways in
morphine abstinence has been shown by Gianutsos et al.

(1973,

l974b). They have found that electrolytic lesioning abolished
the morphine withdrawal aggression in thirty day abstinent
rats while lesioning of the medial forebrain bundle was ineffective in blocking the aggression (Gianutsos et al., 1973,
l974b).
A central component to morphine dependence has been
suggested by the studies by Eidelberg and Barstow (1971) in
the monkey and by Wantanabe (1971) in the rat showing that
dependence on morphine can be induced by chronic intracranial applications of chronic intracranial applic a tions of morphine.

These investigations also demonstrated that withdraw-

al could be precipitated by administration of opioid antagonist into the ventricular fluids.

Herz et al.

(1972) re-

ported that withdrawal signs were elicited in the morphine
dependent rabbits after administration of nalorphine into
the fourth ventricle.

Wei et al.

(1972, 1973) have found

that meidal thalamus and areas in the

diencephalic~mesen

cephalic junction are more sensitive than neocortical,
hippocampal,

striatal, hypothalamic and mesencephalic struc-

tures to naloxone precipitated withdrawal.

Their investiga-

tion indicates that the medial thalamus and rostral mesencphalic structures are involved in precipitated abstinence
behaviors - n e oc ort ical, hippocampal, hypothalamic,

s_tria tal

and tegmental are a s of the brain are relatively insensitive
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to naloxone precipitated withdrawal.

The regional applica-

tion of naloxone to the brain to precipitate abstinence signs
indicates that the site of adaptation to morphine has neuroanatomical specificity.

Wei concluded from these results

that medial thalamic nuclei and closely adjacent structures
may be the primary sites for the development of opioid dependence.

The medial thalamus is also believed to play a

role in tolerance.
in

d~astic

Morphine sulfate administration results

alterations in brain bioelectrical activity.

After repeated drug administrations EEG effects disappear
(Teitelbaum et al., 1974).

An intense morphine response was

seen after the administration of a single dose of morphine
to tolerant rats with lesions of the medial thalamus.

Des-

pite extensive damage to the medial and lateral habernular
nuclei,

the faciculus retroflexus,

and dentate gyous, nalox-

one still reversed the effect of morphine (Teitelbaum et al.,

1974).

It appears that medial thalamic lesions have little

effect on precipitated withdrawal while they have a drastic
effect on sensitivity to morphine in tolerant rats.
Recently the occurrence of opioid receptor binding
has been reported - its localization in the nervous tissue
(Pert and Snyder, 1973).

Their studies of the tissue dis-

tribution provide evidence for the locus of the pharmacologications of opioids.

The greatest amount · of binding oc-

curred in the brain.

Within the brain the opioid receptor

binding revealed the greatest amount of binding in the
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corpus striatum where binding exceeded that of the cerebral
cortex more than fourfold.

Of the known neurotransmitters

only dopamine and acetycholine are found in high concentrate
in the corpus striatum.

Other areas to show binding were

the midbrain cortex, brainstem,

and the cerebellum,

in that

order.
Several studies have taken the approach of lesioning
discrete brain areas and then administering chronic morphine;
upon the termination of morphine withdrawl symptoms are recorded.

It has been found that rats with bilateral lesions

in the anterior cingulate cortex show less opiate directed
behavior following passive morphine injections (Trafton and
Less withdrawal induced weight loss

Marques 1971, 1974).

is seen in rats with posterior medial forebrain bundle lesions.

These lesioned rats conslime morphine solution much

more readily than controls (Glicks and Charap, l97J).

Glick

suggests from this data that the addictive and dependence
properties may have separate mechanisms.
A characteristic behavior of rats undergoing withdrawal from morphine is the appearance of repetitive shaking
movements of the body.

Several investigations have been

undertaken to study the neuroanatomical pathways related to
morphine abstinence,

i n particular the eff' ects of brain le-

sions on the wet shake behavior of morphine abstinence.
Wei et

~·

has reported that naloxone precipitated shakes

are generated in neural elements rostral to the inferior
colliculus and caudal to the fasiculus retoflexus (Wei ~

5 J

al., 1973).

The areas in the rat brain where knife cuts

attenuate the wet shakes reponse to ice water and where
naloxone precipitated the shaking behavior,

bears consider-

able resemblance to the primary motor area for shivering in
the cat described by Hemingway as "··· in the dorsamedial
caudal hypothalamus near the third ventricle just ventral
to the caudal border of the massa . intermedia of the thalamus ••• within the reticular substance dorsal to the marrunillary bodies, dorsomedial to the cerebral peduncles,
stantia nigra and subthalainus •••

11

•

sub-

'This evidence of Wei's

would indicate that the acute and chronic effects of morphine on wet shakes are mediated in the mesodiencephalon
of' the brain.
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H.

The Influence of Chemical Denervation on Morphine Physical
Dependence and Tolerance

1)

5,6-Dihydroxytryptamine
Recently i t was found that a strongly reducing con-

gener of serotonin,

synthesized by Schlossburger and Kuck

(1960), 5,6-dihydroxytryptamine (5,6-DHT) induces a selective
chemical destruction of brain 5-HT nerve terminal (Baumgarten~ al.,

1971) thus reducing brain serotonin contents.

The antinociceptive effect of morphine is not significantly
changed by 5,6-DHT pretreatment (Blasing,

l97J).

The intra-

cerebral administration of 5,6-DH'T in the mouse inhibited
the development of tolerance to and physical dependE-nce on
morphine induced by morphine pellet implantation (Ho et al.,
1972).
2)

6-Hydroxydopamine
Intraventricular administration of 6-hydroxydopamine

(6-0HDA) markedl y reduces brain catecholamines (Bloom ~
al.,

1969).

Morphine administration one week following in-

traventricular administration of 6-0HDA has been found to
-;

increase morphine induced analgesia when measured by the
tail-flick response.

'Die bilateral administration of 6-

0HDA into the medial hypothalamic areas at the level of the
ventricular or t he dorsomedial hypothalamic nuclei also
markedly augmented morphine's effect on the tail-flick
latency.

In addition to these neuroanatomical structures,

when 6-0HDA was injected into the medial forebrain bundle
morphine effec t

on the tail-flick latency was enhanced.

5 .5

Bilateral local administration of 6-0HDA in.to nucleus caudateputamen reduced morphine analgesia (Nakamura et al.,

197J).

This data would seem to indicate that 6-0HDA induced depletion of norepinephrine in the hypothalamus potentiates morphine analgesia whereas depletion of dopamine in the caudate
nucleus _decreases morphine analgesia.
The involvement of brain dopamine in the morphine antinociceptive effect has also been shown in other studies.
Rats treated intracisternally at two week~ o1 age with 60HDA which depleted both brain norepinephrine and dopamine
showed antagonism of morphine antinociception six weeks later when measured by the hot-·plate and tail-flick tests.
Preferential depletion of brain dopamine by desinethylimipramine and 6-0HDA in these rats produced greater antagonism of morphine antinociception in the tail-fl.ick test and
complete antagonism in the hot-plate test (Elchisak et al.,

1973 ) .

A reduced analgesic response to morphine has been

found in both tolerant and nontolerant mice after the intracerebral administration of 6-0HDA without modifying the ·
brain uptake of morphine (Friedler et al.,

1972).

A de-

crease in sensitivity to morphine has also been reported
for tolerant and nontolerant rats following pretreatment by
6-0HDA (Bhargava ~al.,

197J).

The morphine dependent state has also been found to be
altered by 6-0HDA.
naloxone

indu~ed

Precipitated abstinence, measured by

withdrawal jumping in mice was enhanced by

6-0HDA pretreatment; weight loss after abrupt withdrawal was
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also increased by 6-0HDA (Friedler et al., 1972).

Intra-

ventricular injection of 6-0HDA has been found to exacerbate
morphine withdrawal in the rat (Bhargava et al., 1973).
The intraventricuJ_ar administration of 6 -0HDA caused
a marked depletion of brain-norepinephrine in saline treated
rats and in rats treated either chronically or with a single
dose of morphine.

The increase in brain dopamine seen

twenty-four hours after the administration of 6-0HDA to control rats ·was not observed when 6-0HDA was administered to
rats previously treated with morphine dopamine was observed in these rats.

a decrease in brain

One week after treat-

meni, with 6-0HDA both brain noradrenaline and morphine concen~rations

markedly decreased.

While chronic morphine treat -

ment with morphine caused no significant effect on the de pletion of brain norepinephrine after 6-0HDA, chronic treatment with morphine did inhibit the depletion of brain dopamine (Nakamura e t

al., 1972).

These results are interpreted

to suggest that chronic treatment with morphine may induce
changes in the uptake process of the nigrostriatal system.

III.
A.

GENERAL METHODS AND MATERIALS

Animals
Male hooded rats of the Long-Evans strain,

r~ndom-bred,

weighing 250-400 grams were obtained from Charles River
Breed ing Farms, Wilmington, Massachusetts.

Prior to their

use in this investigation the rats were housed in individual
cages and allowed free access to food and water · at all times.
B.

Drugs
Haloperidol (Haldol) was obtained through the courtesy

of McNeil Laboratories, Inc.,Fort Washington, Pennsylvania
and Janssen Pharmaceutica, Beerse, Belgium.

Morphine suJ. -

fate and apomorphine hydrochloride were obtained from the
Mallinckrodt Chemical Works,

St. Louis, Missouri.

The dl-

alpha-methyl -para - tyrosine was obtained from Regis Chemical
Company ,

Chicago, Illinois.

Hal operidol was dissolved in O.J% tartaric acid.

Mor-

phine sulfate and apomorphine hydrochloride were dissolved
in distilled water.

Alpha-methyl-para-tyrosine was sus-

pended in 0.5% carboxyrnethylcellulose.
C.

Brain Lesions
Under ether anesthesia, bilateral electrolyi;ic lesions

were made with a monopolar stainless steel electrode with
a 0.5 mm non-insulated tip.

A current of either 2mA for J O

seconds · duration or lmA for 15 seconds duration generated
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by a Lesion Producing Device (Stoelting Co. Model 58040,
Chicago, Ill.) was passed through the · electrode placed into
the brain with a David Kopf Stereotaxic instrument.
the dorsal cranium horizontal,

With

the coordinates for the nigro-

striatal bundle were l.5 mm posterior to bregma,

2.0 mm

lateral to the midline suture and 8. 5 nun below the surface
of the cranium.

Lesions of the medial forebrain bundle were

placed 2.0 mm posterior to bregma,

l.5 mm lateral to the

midline suture and 8.5 mm below the surface of the cranium
in a horizontal position.
D.

Drug Administration
Rats were made

depende ::.~t

upon morphine by injecting

them intraperitoneally with systematically increasing doses
of morphine sulfate three times a day.

The starting d ose of

15 mg/kg/injection was increased by 15 mg/kg every day until
a dose of 405 mg/kg/day was reached.

In those rats who re-

ceived a terminal dose of 200 mg/kg only two in j ections &
day were given 12 hours apart.

The starting dose of 10 mg/

kg/injection was increased by 10 mg/kg every day until a
dose of 200 mg/kg was reached.

They were maintained at this

dose for at least five days before using them in withdrawal
studies.
In the investigation of recovery from nigro-striatal
lesions, haloperidol, morphine sulfate and alpha-methylpara-tyrosine were administered intraperitoneally twice a
day for a three or six day period with the last injection
being given 24 hours prior to surgery.
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E.

Measurement of Withdrawal Symptoms
Abstinence symptoms were measured after the aburpt ter-

mination of chronic morphine administration and the lesioning
of various brain regions.

Symptoms were measured once every

24 hours for the first 72 hours after the withdrawal of morphine and/or brain lesioning.

In addition to these initial

observations the occurrence of withdrawal symptoms in brain
lesioned subjects was measured three weeks following the production of the lesion.

The rats were removed from their home

cages and placed individually into a novel cage.
were measured for JO minutes.

Symptoms

Prior to these observations

the rats were weighed and their rectal temperature taken
(Martin et al ., 196J).

The abnormal behaviors noted during

the observation period consisted of wet shakes (Martin et
al., 196J), writhing (Bucket, 1964), ptosis and piloerection {Wikler, 1960).

Aggression (Lal et al ., 1971) was mea~

sured seventy-two hours after the last morphine injection.
Violent shaking movements of the head and/or body of the rat
which resemble the action of an animal which has been
drenched with water are defined as wet shakes and the rate
. of occurrence for the observation period is recorded.

Writh-

ing consists of dragging of the abdomen along the floor of
the cage and drawing in of the abdominal wall {Buckett, 1964)
or arching of the back, neither of which is accompanied by
yawning.

The number of wriths occurring during the JO min-

ute observation period was noted.
piloerection,

The presence or absence of

the condition in which the animal's fur stands
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on end, more than a 45~ angl~ is noted during the period of
observation.

Ptosis is defined as the condition where the

rat's eyelids are drooping,

the eye thus appears as slit-

The length of time during the observation period that

like.

the rat was exhibiting ptosis is measured.

The reduction

of body temperature during morphine abstinence, hypothermia,
was measured using a digital thermister thermometer (Digitec
Model 8500-J United Systems, Corporation).

The rectal probe

was inserted Scm and maintained in place for one minute before recording the temperature.

The extent of hypothermia

was calculated from the body temperature one hour after the
last morphine injection or the period just prior to production of the lesion.

The change in body weight during ab-

stinence and/or after brain lesions is calculated from the
body weight after the last injection of morphine and/or the
production of the brain lesion.

To measure aggressive re-

sponses the rats were aggregated in groups of four 72 hours
after the last morphine sulfate injection.

The aggression

was measured as duration of rearing (in seconds), number of
vocalizations and the number of attacks and bites.

Attacks,

including bites . and rearing, were recorded by the experimenter.

Vocalizations w-ere recorded automatically through

an Audio Threshold relay.
F.

Histology
Representative animals from the various drug-treated

and saline control groups were used to evaluate the site of
lesioning.

Those subjects chosen for evaluation were per-
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fused with Dietrick 1 s Fixative at the conclusion of the experiment.

Dietrick's Fixative was prepared by combining

1800 ml of water,

90 ml of 95% ethyl alcohol;

formaldehyde and 60 ml of glacial acetic acid.

JOO ml of 40%
The brain

was then removed from the cranium and allowed to harden in
Dietrick's Fixative.
for at least 24 hours,
al hours.

After the brain tissue had hardened
it was then washed in water for sever-

Increasing concentrations of ethanol were used

to dehydrate the tissue prior to cleansing with chloroform.
When each brain was embedded in paraffin, 10 micron sections
were taken from the area containing the lesion site.

The

sections were then mounted on slides and stained with
Harris' hematoxglin and eosin according to the method of
Luna (1968).
1)

Physical Characteristics of the Brain Lesion
The typical localization of the nigro-striatal lesion

employed in these experiments based on examination of histological material from a representative animal is shown in
Figure 1.

Examination of these sections showed the lesion

to be localized in the area of the lateral hypothalamus,
with destruction of the nigro-striatal pathway and some
portions of the medial forebrain bundle.
When a current of lmA for 15 seconds was employed
microscopic examination showed the lesion to have destroyed
an area of O.JO .±. O.OJ mm in diameter;
four representative subjects.
lesion is shown in Figure 2.

this is a mean of

The area destroyed . by this
Increasing the current and
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duration to 2mA for JO seconds produced a greater destruction of brain tissues.

The mean lesion diameter was increased

to o.47 + O.Ol nun when measured in four.animals.
destroyed by this lesion is shown in Figure

The area

J.

In those experiments where the lesion was directed at
the medial forebrain bundle microscopic examination showed
the damage to be localized to this area.

In some cases some

slight damage to the immediately adjacent nigro-striatal fibers cannot be ruled out.
2)

Neurochemical Effects of the Lesion
In order to further confirm the site of the lesion to

the nigro-striatal dopamine neuron system the dopamine concentration in the corpus striatum was determined spectrofluorometrically following either a lmA 15 second or 2mA JO
second brain lesion.
To evaluate dopamine levels after nigro-striatal lesioning the animals were starved for 18-24 hours prior to
being sacrificed by decapitation.

The brains were rapidly

removed from the cranium and the two cerebral hemispheres
separated.

The lateral ventricle

vas opened to expose the

corpus striatum which was then removed.

All of these manip-

ulations were carried out on ice and with ice-cold surgical
equipment.

Striata obtained from lesioned and non-lesioned

subjects were separately weighed and then homogenized in

J ml of 0.4 N perchloric acid containing 0.05% sodium metabisulfite.

The homogenate was then transferred into a
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centrifuge tube.

The ,homogenizer was rinsed with l ml per-

chloric · acid solution which was added to the homogenate.

The

homogenate samples were then centrifuged at 10,000 RPM for
lO minutes in

·

a Servall RC 2B refrigerated centrifuge.

The supernatant from each centrifuge tube was transferred into a large centrifuge tube to which 10 ml of 0.5 M
tris buffer (pH 9.5) was added.
sample was 8.5

±

The resultant pH of the

0.1. The samples were then poured onto alu-

mina columns and allowed to pass -through at a rate of JO
drops per minute.

After the solution had run through the

alumina column 5 ml cif deionized glass distilled water was
added to the large centrifuge tube which was then passed
through the column. The eluate collected was discarded.
dopamine from the alumina column was then extracted by
of 0.2 N acetic acid.

The

4

ml

The acetic acid eluate was collected

in a graduated centrifuging tube containing 1 ml of EDTAreagent.

A two and a half ml sample from each test tube was

used for the dopamine determination.

The two and a half ml

sample of 0.2 N acetic acid eluate was transferred into another test tube and tci it 0.2 ml of

iod~ne

solution was added.

Each test tube was shaken in a Vortex Gemie test tube shaken
for l5 seconds and after exactly J minutes, 0.2 ml of alkaline
sulfite was added.

The tissue blanks were obtained by the

residual 0.2 N acetic acid eluate.

The tissue blanks were

prepared by reversing the addition of iodine and alkaline sulfite solution.

Exactly J minutes after the addition of al-

kaline sulfite solution 0.2 ml of 5 N acetic acid solution
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was added to each test tube.

Again each

te~t

tube was shaken

for 15 seconds, placed into a bath of boiling water for 5
minutes and then cooled to room temperature.

The concentra-

tion of dopamine was estimated by reading the samples at
370 NM while activated at J20 NM on the Amico-Bowman spectrafluorometer.

The reagent blank consisted of all the re-

agents but dopamine.

The concentration of dopamine in the

experimental samples was determined by comparing the fluorescence with the known concentration of a standard dopamine
solution.

The calculated concentration of dopamine was then

expressed as micrograms of dopamine per gram of wet tissue.
Twenty-four hours following the lmA 15 second lesion
there was a non-significant increase in the corpus striatal
dopamine levels.

The average dopamine concentration of the

corpus striatum in non-lesioned rats was 8.63 + o.49 ug/g.
At both four and seven days following this lesion,

corpus

striatal dopamine levels were significantly decreased,
Student's ' t '

test (pL0.05).

The decrease in dopamine

levels was greatest on the seventh post-lesion day.

These

results are summarized in Figure 4.
Striatal dopamine levels were seen to significantly
increase, Student's ' t '

test

(p.t'. 0.05) , when more extensive

nigro-striatal lesions,

2mA for JO seconds, were made

twenty-four hours prior to measurement..

The corpus striatal·

dopamine concentration was fou....'1.d to be 6.Jl
non-lesioned controls.

±

o.40 ug/g in

Four days after lesioning there was

a dramatic and significant Student's ' t ' test (pLo.05), de-
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crease in the concentration of striatal dopamine.

Th e

levels of striatal dopamine seven days foll-0wing this large
lesion were not measured due to the death , of all experimental
animals.
Figure 4.

These changes in dopamine levels are shown in
The results achieved here correspond well with

those of other i nvestigators (Faull et al., 1969; Anden,

e .t

al., 1972; Agid et al., 1974).
G.

Statistical Analysis
An analysis of variance for repeated measures was used

to test for significant differences between treated and
control conditions in the nigro-striatal lesion induced
weight loss experiments.
The two-tailed Student's ' t '

test for independent means

was used to test for the differences between the means of
-lesioned and non-lesioned groups in the morphine withdrawal
experiments.

The level of significance was chosen to be

p L0.05 for rejection of the null hypothesis.
The results obtained from the effect of drugs pretreatment on survival after extensive ni-g ro-striatal lesions
was analyzed by the Chi-Square test.

FIGURE l.

Typical Cross Section of Rat Brain Showing
Nig~o-Striatal

Ue~tru6tion.
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FIGURE 2.

Representative Small Nigro-Striatal Lesion
Superimposed on a Figure From the Konig
and Klippel Atlas

(1963).
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FIGURE

J.

Representative Large Nigro-Striatal Lesions
Superimposed on a Figure From the Konig and
Klippel Atlas

(1963).
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FIGURE 4.

Striatal Dopamine Levels at Various Time Intervals Following Bilateral Lesions of the
Nigro-Striatal Pathway Expressed as Percent
of Non-Lesioned Controls.
Were Measured at l

(N=9),

Dopamine Levels

4 (N=ll) and 7 (N=8)

Days Following 15 Sec lmA Current Lesions and
at l

(N=8) and

4 (N=8) Days After J O sec 2rnA

Current Lesions.
Given in the Text.

Control Dopamine Levels are

30sec. 2mA current
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DAYS AFTER
NIGRO-STRIATAL
LESIONING

IV.

EFFECT OF HALOPERIDOL, METHYL-PARA-TYROSINE
AND MORPHINE ON WEIGHT LOSS AND LETHALITY
DUE TO NIGRO-STRIATAL LESIONS

A.

Introduction
Bilateral lesions of the lateral hypothalamus produce

a complete cessation of eating and drinking (aphagia and adipsia) eventually leading to death in spite of ample food and
water availability (Anand and Brobeck, 1951).

Although ex-

tensive information has been accumulated on the changes in
food and water regulation following LH lesions, knowledge
about anatomical structures is still incomplete.

Several

newer experiments have questioned the role of the LH as a
"feeding center," and several studies have Sliggested that
the critical areas for producing aphagia and adipsia may be
outside or include only a far lateral segment of the lateral hypothalamus (Morgane,

1961; Gold, 1961; Grossman and

Grossman, 1971; Wampler, 1971).

These critical areas in-

clude portions of the globus pallidus, the medial portion
of the internal capsule, and a small portion of the lateral
hypothalamus area adjacent to the internal capsule.

Sever-

al fiber systems pass through these areas and are known to
regulate the content of norepinephrine,

dopamine and sero-

tonin in the telencephalon.
One such fiber system,

the nigro-striatal bundle (NSB),
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regulates the dopamine content of the neostriatum (the caudate and putamen).

Nigrofugal fibers · pass through areas de-

scribed as critical for producing the LR .syndrome.
sutaining a complete electrolytic

Rats

(Oltsman and Harvey,

1972) lesion of the NSB or chemic a l

lesion (Ungerstedt, 1970,

1971) of the NSB show a severe aphagia and adipsia resulting
in death, unless the animals are force-fed.
When animals that have received lateral hypothalamus
lesions are force-fed they gradually recover from their feeding deficits (Teitelbaum and Epstein, 1962).

The basis of

recovery after lateral hypothalamic lesioning is not known
des:")ite much investigation. A denervation supersensitivity
model may be useful in explaining recovery (Sharpless, 1 964 ).
If a supersensitivity phenomenon were the factor responsible
for the recovery of food regulating behavior, then certain
results could be predicted; namely, neurons which were made
supersensitive at some time prior to destruction of the NSB
could then be expected to facilitate recovery.
Administration of alpha-methyl-para-tyrosine (MPT),

a

known blocker of catecholamine synthesis (Nagatsu et al.,
1964) will produce a partial denervation of catecholamine
pathways (Tarsy and Baldessarini, 1973).

Recent research

has shown that pret reatment with MPT before lesioning of the
lateral hypothalamus facilitates recovery from the syndrome
(Glick et al.,

1972).

all the catecholamines,
Glick et al.

However, MPT blocks the synthesis of
and further,

the lesion used by

(1972) was located in the lateral hypothalamus;

thus,

their results do not distinguish between noradrenergic

and dopaminergi c e ffects . either pharmacologically or neuroanatomically.

The issue is especially significant since

the suggestion has been made that reccvery of nutritive regulation after lateral hypothalamus lesioning is dependent
upon recovery within a noradrenergic reward system {Berger
et al.,

1971, 197J).

This experiment was undertaken to establish the role
of dopaminergic neurons in the regulation of body weight.
· Both partial (lmA 15 sec)

and extensive (2mA JO sec

) nigro-

striatal lesions will be produced and post lesion recovery
studied.

Rats were injected with either saline, haloperidol

or alpha-methyl-para-tyrosine for three days prior to the
production of partial {lmA 15 sec

) nigro-striatal lesions.

Alpha-methyl-para-tyrosine pretreatment were employed since
previous reports indicated that it facilitated recovery from
lateral hypothalamic lesions.

Haloper~dol

served to dis-

tinguish between dopaminergic and adrenergic mechanisms in
recovery.

Following lesioning animals were observed daily

for changes in b ody

weigh~.

Drug treated groups were com-

pared with salin e controls to determine if drug pre-treatment effected weight changes follo wing nigro-striatal lesioning.

Prior to extensive {2mA JO sec

) lesioning of the

nigro-striatal t ract either saline, haloperidol or morp hine
were administered for a six day period.

Since pre vious

evidence sugge st ed that acute morphine blocks dopamine receptors it was t hus incorporated to test the role of
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dopaminergic supersensitivity in post lesion recovery.

These

drug treated animals were compared to saline treated controls
with respect to lesion induced weight changes and lethality.
It was hypothesized that lesioning of the nigro-striatal
tract would result in aphagia and ad-ipsia as indicated by a
loss of body weight.

Drugs which reduce dopaminergic recep- .

tor activity are hypothesized to facilitate recovery from
lesion induced weight loss,

thus establishing a role for

brain dopaminergic systems in the regulation of body weight.
B.

Method
Haloperidol (o.4 mg/kg), methyl-para-tyrosine (50 mg/

kg) or saline were administered intraperitoneally (i.p.)
twice a day (8 a.m.

and 8 p.m.) for three consecutive days

with the last injection given 24 hours prior to th e production of a partial (lmA 15 sec ) bilateral nigro-striatal
lesion.

A six-day pretreatment period of morphine (30 mg/

kg),haloperidol (2 mg/kg) or s a line,

injecte d t wice daily

was given prior to the production of an extensive (2mA J O
sec ) bilateral nigro-striatal lesion.

The last injection

was given 24 hours before surgery.
Throughout the experiment the rats were house:l individually and given free a ccess to dry food and water.
feeding was not attempted.

Body weights were taken daily

during both pre- and post- lesion periods.
of a death in either the experimental or
recorded.

Force

The occurrence

contr~l

groups was

A represent ative group of surviving rats were

sacrificed 16 days after the production of the lesion and
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the lesion si .t e determined by histological procedures as described in Chapter III.
C.

· Results
Those animals receiving partial (lmA 1.5 sec

) nigro-

striatal lesions continued to lose body weight until the
fifth post-operative day as can be seen from Table 1.

Ana-

lysis of variance for repeated measures (Winer, 1962) showed
that

groups pretreated with alpha-methyl-para-tyrosine

tho~e

or haloperidol lost significantly (p L 0.05) less body weight
than did saline controls.

The extent of total weight loss

was diminished in these drug treated animals as evidenced by
their higher percentage body weights as compared to saline
treated controls.

These re3ults are shown in Figure 4.

The

saline treated controls showed a greater loss in gram of
body weight indicating that the drug treated group began to
recover earlier.

These results are SLurunarized in Figure 5.

When a current of 2mA for a JO second duration was employed to make a more extensive lesion of the nigro-striatal
tract the resulting aphagia and adipsia produced death in
all saline treated controls.
Table 2.

These results are shown in

All of the rats in the control group died within

two weeks of the lesion, -nearly half of them in less than
eight days.

Percentage body weight changes were similar

for both treated and control groups for the first six postlesion days as can be seen in Figure 6. From the 9th to the
14th post-operative day,

the saline treated rats showed a

greater loss in grams of body weight than did the groups
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Table l.

Weight Changes 1 Following Small Lesions 2 of the
Nigro-Striatal Bundle with Pretreatment by Haloperidol3 or Alpha-Methyl-Para-Tyrosine4-6

Treatment
Postoperative
Day

Saline
(N=8)

Haloperidol
N=8)

Methyl-pN=5)

1

89.8 + o.4

93.4 + 1.4

91.6 + 1.6

2

85.3 ±. 0.9

92.0 + 1.6

88.2 + 2.8

3

83.7 ±. 1.1

90.0 + 1.3

87.6 + 3.6

4

83.6 + 2.0

88.8 ±. 2.2

86.4 + 3.9

5

84.1 + 2.7

90.7 + 1.5

89.2 + 5.1

6

86.5 + 2.6

91.8 ±. l.J

91.0 + 4.9

7

86.4 + 2.9

93.3 + 1.4

90.2 + 4.9

1.

Weights are expressed as means and standard errors of
percent weight relative to preoperative weight.
Number of subjects per condition is indicated in parentheses.

2.

Each subject was lesioned bilaterally using 1 mA for
15 sec.

3.

0.8 mg/kg/day was administered i.p. for 3 days.

4.

100 mg/kg/day was administered i.p. for 3 days.

5.

An analysis of variance for repeated measures

6.

Preoperative weights were J67.8 .±. 6.5, 318.4 ±. 19.1,
371.5 ±. 9.2 grams respectively for saline, haloperidol
and methyl-p-tyrosine treated groups.

14

comparing the haloperidol and control conditions on days
2 through 7 indicated a significance (F=7.6, p L.05 for
df = 1, 14).
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Table 2.

1
2
Weight Changes Following Large Lesions of the
Nigro-Striatal Bundle With Pretreatment by Morphine3 or Haloperidol4-5

Postoperative
Day

Treatment
Morphine

Saline

Haloperidol ·

2

87.l+l.J (ll)
80.4+1.l (ll)

88.4+0.6 (15)
81.7+0.6 (15)

89.J+l.2 (28)
8J.O.±.l.l (28)

J

74.7±1.l (11)

76.8+0.7 (15)

77.6+l.l (27)

4

70.9±1.0 (ll)

7J.0+0.8 (15)

7L~.l.±l.2

5

67.0+l.l (ll)

69.4+0.9 (15)

70.0±1.4 (25)

6

6J.O±l.4 (10)

66.2+0.7 (15)

68.7±1.6 (24)

7

60.7±1.8 ( 7)

6J.9.±.l.4 (lJ)

67.1±2.0 (21)

8

60.6±2.J ( 4)

65.J.±.2.8 (10)

67.2.±.2.7 (16)

9
10

54.5±3·5 ( 2)

69.7+4.2 ( 7)

70.9+3.5 (12)

51.0±2.8 ( 2)

75 .0+4.5 ( 6)

70.5+4.2 (11)

ll

48.0±l.4 ( 2)

75.8.±.5.l ( 6)

76.0.±5.6 ( 8)

12

46.0+0.0 ( l)

76.1.±.5·6 ( 6)

77.8.±7-1 ( 7)

lJ

44.o+o.o ( l)

76.8.±.6.4 ( 6)

90.3+7.8 ( 6)

14

( o)

78.4.±6.8 ( 6)

9l.4.±4.4 ( 5)

l

(25)

l.

Weights are expressed as means and standard errors of
percent weight relative to preoperative weight.
Number of subjects per condition is indicated in parentheses.

2.

Each subject was lesioned bilaterally using 2 mA for
JO sec.

J.

60 mg/kg/day of morphine sulfate was given i.p. for 6
days.

4.

4 mg/kg/day of haloperidol was given i.p. for 6 days.

5.

Preoperative weights were Jl6.8+2J.J, J65.4+10.7,
JJ0.7.±7.4 grams respectively fo; saline, morphine and
haloperidol treated groups.
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pretreated with haloperidol (4 mg/kg/day) or morphine sulfate
7.

(60 mg/kg/day).

These results are summarized in Figure

A significantly greater number of rats pretreated with

morphine or haloperidol were still alive on the 15th postoperative day when compared to saline treated controls (morphine vs saline p

L 0. 001

by the Chi-Square test).
D.

and haloperidol vs saline p L

o. Ol

These data are shown in Figure 8.

Discussion
Tne extent of weight loss in the lesioned animals was

dependent upon the amount of nigro-striatal damage.

These

results support previous suggestions (Oltsman and Harvey,
1972; Ungerstedt, 1970, 1971) that the destruction of the
riigro-striatal pathway is critical fcir the production of
the lateral hypothalamic syndrome. Facilitations of recovery
f'rom the syndrome produced by large lateral hypothalamic
lesions has previously been demonstrated with methyl-paratyrosine treatment (Glick et al., 1972), and the present
results show an analogous effect of methyl-para-tyrosine
on recovery from nigro-striatal damage of a less extensive
area.

Recovery was also facilitated by pretreatment with

haloperidol.

Lethality from massive nigro-striatal damage

was reduced if subjects were treated with haloperidol" or
morphine for a six-day period prior to surgery.
A definite mechanism underlying recovery from the destruction of the nigro-striatal pathway cannot as yet be
proposed.

Several suggestions are worthy of

~onsideration,

first an increase in sensitivity of postsynaptic receptors
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(Cannon and Rosenbleuth, 1949; Stovraky, 1961; Glick et al.,
1972); s~condly the re g enera tive sprouting from transected
axons (Katzman e t

a l., 1971; Nygren e t

al., 1971); third and

lastly is an increase in catecholamine turnover in surviving neurons

(Bloom et al., 1969; Uretsky et al., 1971; Agid

et al., l97J).

Any or all of these changes are likely to

promote recovery.

All the drugs found active in promoting

recovery have one property in common,
dopamine deficiency at receptor sites.

that is,

they produ.ce

Alpha-methyl-para-

tyrosine is a well-knoi.m i;nhibitor of catecholamine synthesis (Nagatsu et al.; 1964) haloperidol blocks dopamine
receptors directly (Janssen, 1967; Van Rosswn, 1967; Anden
et al., 1970) and morphine blocks dopamine receptors indirectly, possibly through an effect on non-dopaminergic
neurons - (Puri et al.,

l97J).

The other pharmacological

effects of the drugs employed in this study are not common
to all three drugs.
A drug induced deficiency of receptor activity can
cause both an increase in receptor sensitivity as a consequence of pha rmacological denervation (Sharpless, 1964)
and stimulate n e uronal feedback mechanism (Fuxe and
Ungerstedt, 197 0).
(Gianutsos et a l.,

Chronic treatment with haloperidol
l974a, 1975), methyl-para- t yrosine

(Tarsy and Baldessareni, 1973), and morphine sulfate (Puri
and Lal, 1973 ) is known to cause supersensitivity of dopamine receptors in the central nervous system.

Both

84

haloperidol and morphine sulfate increase dopamine synthesis in the nigro-striatal system (Janssen, 1967; Gunne
et al., 1969; Puri~ al., 1973).
these drugs,

The pretreatment with

that increase neurotransmitter synthesis,

could promote the development of a compensatory change in
the level of activity of the surviving dopamine containing neurons (Bloom et al., 1969; Uretsky et al., 1971;
Agid et al., 1973).

The stimulation of neurotransmitter

synthesis could possibly accompany stimulation of several
other processes which play a part in the regenerative
process, which,

of the suggested effects of these drugs

under consideration might actually account for the .:>bserved
promotion of recovery after nerve injury needs further inve'stigation.

V.

MODIFICATION OF NARCOTIC WITHDRAWAL SYMPTONS
BY NIGRO-STRIATAL AND MEDIAL FORE
BRAIN BUNDLE LESIONS

A.

Introduction
The participation of dopaminergic neuronal systems in

narcotic dependence and wj_ thdrawal has been suggested in recent years by several lines of evidence.

Morphine with-

drawal aggression in dependent animals can be selectively
potentiated by dopam.inergic stimulating agents and blocked
by drugs which block dopamine receptors (Puri et al., 1971;
Lal and Puri, 1972; Puri and Lal, 1973).

Haloperidol, a drug

with some specificity for blocking dopamine receptors (Janssen
1967; Von Rossum,

1967; Anden et al., 1970) has been reported

--

to reduce morphine withdrawal syndrome in animals and humans (Lal et al., 1971; Kark alas and Lal, 1972).

Haloperidol

also reduces the self a dministration of morphine in addicted
rats (Hanson and Cimine-Venema, 1972) and monkeys
and Kerr, 1972).

(Pozuelo

Lesions placed stereotaxically in monkeys

in the origin of the nigro-striatal system and the nucleus
tegmenti ventralis, known to be mainly dopaminergic pathways,

abolish craving for morphine and the phenomena of with-

drawal,

as evidenced,

respectively by lack of bar pressing

and by lack of withdrawal manifestations (Pozuelo and Kerr,
1972).

Further evidence for the involvement of dopamine
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pathways in morphine abstinence has been shown by Gianutsos
et al.

(1973,1974).

They have found that electrolytic le-

sioning of the nigro-striatal bundle abolished morphine
withdrawal aggression in thirty-day abstinent rats while lesioning of the medial forebrain bundle was ineffective in
blocking the aggression (Gianutsos et al., 1973, 1974b).
Further evidence for the interaction between brain
dopamine and morphine comes from biochemical studies.

Acute

morphine elevates brain homovanillic and 3-4 dihydrophenylacetic acid (:Fukui and Tugaki, 1972; Kuschinsky and Hornykiewicz, 1972), increase the synthesis of labeled dopamine
from labeled tyrosine in the brain (Clouet and Ratner, 1970;
Fukui et al.,

1972; Smith et al., 1970, 1972) and acceler-

ates the disappearance of dopamine after the administration
of .alpha-methyl-para-tyrosine (Gunne ~al.,
al., 1973).

1969; Puri et

These observations strongly suggest the involve-

ment of dopaminergic pathways in morphine action and dependence.
In order to understand the role of the nigro-striatal
dopaminergic pathways in morphine dependence,

this study in-

vestigated the effect of nigro-striatal lesions produced
prior to and following the production of dependence on withdrawal symptoms.

Morphine dependence was produced in rats

with partial (lmA 15 sec

) nigro-striatal lesions.

After

the abrupt termination of morphine injections narcotic withdrawal symptoms we re compar ed between lesioned and nonlesione d groups. Both partial (lmA 15 sec

) and extensive
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(2mA JO sec ) nigro-striatal lesions were produced during
the withdrawal period.

These lesions were made at both 0 and

48 hours after the terminal dose of morphine.

Withdrawal

symptoms were measured in lesioned and non-lesioned groups
and compared.

The aforementioned experiments were conducted

at two different levels of morphine dependence,

at terminal

doses of 200 and 405 mg/kg/day of morphine sulfate.

The

dopaminergic stimulating agent, apomorphine (A..~den ~al.,

1967; Ernst, 1967) was

administered to both intact and

nigro-striatal lesioned morphine withdrawn subjects to further assess the role of dopaminergic receptor activity in
the abstinence phenomena.

In order to determine if the re-

sults were specific for the dopaminergic system the medial
fore brain bundle,

a noradrenergic and serotonergic neuron

system, was also lesioned after the production of dependence
and abstinence signs observed.

It was hypothesized that

nigro-striatal lesions would modify the withdrawal symptoms
that involved dopaminergic mechanisms.
B.

Method
Male hooded rats were housed in individual cages dur-

ing the addiction and withdrawal phases of these experiments.
Brain lesions were made under anesthesia either prior to or
following the production of dependence.

At the completion

of each experiment a representative group of animals were
sacrificed for histological localization of the lesion site.
Rats were made dependent upon morphine by injecting
them intraperitoneally with systematically increasing doses

8()

of morphine sulfate three times a day.

The starting dose of

15 mg/kg/injection was increased by 15 mg/kg every day until
a dose of 405 mg/kg was reached.
In those rats who received a terminal dose of 200 mg/
kg orily two injections a day were given twelve hours apart.
The starting dose of 10 mg/kg/injection was increased by 10
mg/kg every day until a dose of 200 mg/kg was reached.

They

were maintained at this dose for at least five days after
which no morphip.e was injected.
Abstinence symptoms were measured after the abrupt
termination of chronic morphine admi ni stration.

Symptoms

were measured once every 24 hours for the first 72 hours after morphine withdrawal.

The rats were removed from their

home cages and placed individually into novel cages.
toms were measured for

JO

Symp-

minutes; prior to observation

rats were weighed and then rectal temperature taken.

The ab -

normal behavior noted during the observation period consisted
of wet shakes, writhing, ptosis and piloerection.

Aggression

in response to social grouping was measured seventy-two
hours after the last morphine sulfate injection.

A more de -

tailed description of these procedures can be found in Chapter III.
C.

Results

1)

Modification of' Narcotic Withdrawal Symptoms by -NigroStriatal Lesioning
a.

Lesions made prior to the production of dependence
Partial destruction of the nigro-striatal path-

way prior

t~

the production of morphine dependence modified

the intensity of the narcotic withdrawal syndrome.

Wet

shakes and ptosis were seen to significantly (pL0.02) increase when compared to non-lesioned addict e d controls by
the Student's
spectively.

't'

test at 24 and 48 hours of withdrawal re-

The Student's ' t '

test indicated a significant

(pL0.05) lesion effect on weight loss at 24 and 48 hours of
withdrawal.

Hypothermia was found to be significantly

(pL0.001) increased over the non-lesioned groups by the
Student's ' t ' test at 48 hours of withdrawal.
vides a summary of these results.

Table J pro-

There was a significant

reduction in 72 hour morphine withdrawal aggression in the
animals receiving nigro-stri a tal lesions prior to the production of dependence.

These results are shown in Table 4.

Replication of this e x periment in which the terminal
dose of morphine was increased to 405 mg /kg/day yielded
similar results.

Analysis of the data with the Student's

't' test showed that lesioned subjects showed significantly
(p L. 0. 001) more wet shakes at 48 and 72 hours of withdrawa l
than did non-lesioned addicted controls.

Writhing was found

to be significantly (pL'. 0.01) decreased at 72 hours of withdrawal.

At 48 hours of withdrawal lesioned rats showed a

significant (p L O.Ol) increase in ptosis time and weight
loss when compared to non-lesion addicted controls by the
Student's ' t ' test.

Using this same statistical test a

significant (p L 0. 001) decrease in 24 hours withdrawal hypothermia was found.

J.

These results are summarized in Table

Morphine withdra wal aggre ssion measured at 72 hours of

Table

J.

Modification of the Narcotic Withdrawal Syndrome by Nigro-Striatal Lesioning
Prior to the Production of Morphine Dependence
Non Addicted

Symptoms10
(Hours of
Withdrawal}

Addicted

200 mg/kg/day
NonLesioned

NonLesioned

1. 5±1.1

0.5.±.0.5
0.2+0.2
0.0±0.0

Lesioned

0.2±0.1
0.2.±.0.l
0.2±0.1

0.5+0.2
l.0+0.4

Lesioned

Lesioned

2 .0.±.0.J
5.6+0.7
6.1+0.7

5. L~.±.1. 1 3
7.8+1.4
7. J +l.6

. 9
9.1.±.1.J
6.9+0.9
6.J±0.6

10.6+2.0
5
lJ.6+1.7
5
lJ. 6.±.l. 7

0.5+014

o.L~+O.O

l.O+O.L~

O.J.±.0.1

1.4+0.5
1.0.±.0.J

7
l.9+0.J7
2.5+0.4
8
J.2±0.9

2.l+0.8
2.0+0.84
0.5.±.0.2

Writhing

24
48
72

O.O+O~O

o.o±.o.o
o.o+o.o

405 mg/kg/day
NonLesioned

Wet Shakes

24
48
72

1

Piloerection
{No positive/No observed)
2L1

48
72

4/L~

2/4
2/L~

15/15
15/15
15/15

lJ/lJ
12/lJ
lJ/lJ

27/27
27/27
16/16

16/16
14/14

o.o.±.o.o
o.o+o.o
o.o.±.o.o

o.o+o.o
0.0,±.0.0
0.0,±.0.0

28+21
o.o+o.o
0.0±0.0

206±1163
L~ J8+158
7l1 +l-11

6
101,±.287
87.-t.308
201+60

92+4J 4
5J6+1J4
227,±.92

-

2.6±0.7
25.J,±.2.7
J0.9,±.2.1

2
10.J.±.J.OJ
J5.9+J.O
JJ.4+4.4

12. 8+ .l . 5 9
26.5±1.5
J2.8,±.J.O

11. 0,±.l. 9 4
J4.5+2.5
J7.5+4.J

Ptosis Time

24
h8

72
Weight Loss

24
4.8
72

ll~/16

0/12
0/12
0/1 2

-

l,O

p

t
~t;
·,
Table J - Continued

Hypothermia
24

48
72

o.1+0.01
0.2+0.40
o.o+o.oo

l.~7+0.06

1.75+0.07
1.70+0.08

1.80+0.09
.....
5
2.79+0.18
1.98.±.0.11

2.05+0.07
1.88+0.06
l.J5+0.10

1.59+0.08 5
1.90+0.10
1.64+0.ll

1.

lmA for 15 seconds.

2.

Significantly different from non-lesioned addicted controls based on Student's It I
test (pL0.05).
Significantly different from non-lesioned addicted controls based on Student's It I
test (p L 0. 02) .
Significantly different from non-lesioned addicted controls based on Student's It I
test ( p I- 0. 01) •
Significantly different from non-lesioned addicted controls based on Student's It I
test (pL0.001).

J.
4.
5.
6.

Significantly different from 200 mg/kg/day morphine withdrawal, based on Student's
It I test (pL0.05).

7.

Significantly different from 200 mg/kg/day morphine withdrawal, based on Student's
It I test (ptt:o.02).

8.

Significantly differ~nt from 200 mg/kg/day morphine withdrawal, based on Student's
It I test (pL0.01).

9.

Significantly different from 200 rng/l}:g/ day morphine withdrawal, based on Student's
It I test (p '0. 001 ).

10.

All data are expressed in terms of means and standard errors unless otherwise indicated.
The number of animals employed in each group is indicated as the denominator of the fraction used to express the occurrence of piloerection.
Ptosis
time is expressed in seconds, weight loss in grams and hypothermia in degrees
centigrade.

\0

.....

Table 4.

Seventy-Two Hours Withdrawal Aggression in Rats Receiving Brain Lesions

Mean + S.E.
Treatments

Attacks

N

Rearing

Vocalization

Addicted to 405 mg/kg/day
Intact Controls

5

J2±.2

J014±.19J

Small NSB Lesion
1
Prior to Addiction

l

JO

1261

527

Small NSB Lesion
After Addiction1

l

J

286

80

Large NSB Lesion
After Addiction2

l

21

J09

Jl9

Small NSB Lesion
Af'ter Addiction 1

l

14

997

29J

Large NSB Lesion
After Addiction2

l

5

56

69

1809±.J61

Addicted to 200 mg/kg/day
Intact Controls

J

9±6

Small NSB Lesion
1
Prior to Addiction

2

O+O

Small NSB Lesion
After Addiction 2

2

58.:t.4

26J9+l65

Large NSB Lesion
After Addiction 2

2

14±7

292.:t.16

1811±.868
J5+19

929+4 5Lt.
lJ±.24
827+44
209±.110
\0

l.

1 mA 15 s e c

2.

2 mA JO sec

!\)
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withdrawal showed a reduction in rearing and vocalization in
the lesion addicted groups.

These results are shown in Table

4.
The withdrawal syrnptonl3 exhibited by rats addicted to
200 and 405 mg/kg/day of morphine were compared by the Student's

' t ' test.

Wet shakes were increased in those rats

withdrawing from 405 mg/kg/day at 24, 48 and 72 hours but
signi_ficance (pLO.OOl) was achieved only at 24 hours.

Writh-

ing in these rats was significantly (pL0.02) increased at
24,

48 and 72 hours.

Ptosis was significantly increased at

24 (pL 0.05), 48 (pL 0.02) and 72 (pL 0.01) hours of withdrawal _in rats withdrawn froM 405 mg/kg/day of morphine as
compared to those withdrawn from 200 mg/kg/day.

Weight loss

was found to significantly (pL0.001) increase at 24 hours.
Increased hypothermia was observed in rats withdrawn from
405 mg/kg/day but this increase failed to achieve significance.
b.

These results are summarized in Table

J.

Lesions made after the production of morphine dependence.
1.

Effect of small nigro-striatal lesions
Rats made dependent,

200 mg/kg/day terminal dose,

and lesioned (lmA for 15 sec ) following the last injection
of morphine showed a general increase in withdrawal intensity.
Withdrawal wet shakes in the lesioned rats were significantly

(pL 0.001) increased at 24 and 48 hours of withdrawal when
compared to their non-lesioned counterparts by the Student's
't' test.

At 72 hours of withdrawal a significantly (pL0.02)

increased amount of writhing was observed in lesioned subjects.

94

Ptosis time was found to significantly (p L

0. 05) increase in

nigro-striatal lesioned subjects by the Student's ' t '
at 24, 48, and 72 hours of withdrawal.

test

When the same sta-

tistical test was employed for the effect of the lesion on
weight loss it showed the lesion groups to have lost a significantly (pL0.001) greater amount of body weight at 24,
48 and 72 hours of withdrawal than non-lesioned controls.
The Student's

' t ' test showed a significant (pL0.05) in-

crease in hypothermia at 72 hours.

A significant (p L 0. 05)

' lesion effect was observed for wet shakes and writhing in
non-addicted rats.

Weight loss was also seen in non-ad-

dieted lesioned rats.
5.

These results are summarized in Table

Seventy-two hour morphine withdrawal aggression was ap-

parently increased by the lesion,

as showTI in Table 4.

When the terminal dose of morphine was increased to
405 mg/kg/day a similar lesion effect was noted.
dent's

't'

The Stu-

test showed significant increases in wet shakes

at 24 (pL0.02), 48 (p.Lo.05) and 72 (pL0.001) hours in
the lesioned groups as compared to the non-lesioned ad~-

dieted controls.

Writhing was found to be significantly

(pL0.05) decreased at both 24 and 72 hours of withdrawal
in the nigro-striatal lesioned groups.

Significant (p~ 0.001)

increases in ptosis time and weight loss were seen in the
lesion groups when compared to the non-lesioned controls
by the Student's

't'

test.

Application of this statistical

test to withdrawal hypothermia showed a significant (pL0.001)
decrease at 24 hours and a significant (p£0.0l) increase at

Table 5.

.

.

.

.

Narcotic Withdrawal Symptoms in Rats With Small Nigro-Striatal Lesions
After the Terminal Dose of Morphine Sulfate
Non-Addicted ·

Wet Shakes
24
48
72
Writhing
2L~

48
72

Made

Addicted
200 mg/kg/day

Symptoms6
(Hours of
Withdrawal}

1

405 mg/kg/day

NonLesioned

Lesioned

NonLesioned

Lesioned

NonLesioned

Lesioned

0.2.±.0.l
0.2+0.1
0.2.±.0.l

5
J.0.±.0.63
5.Lt.±.1.94
2.6.±.0.8

2.0+0.J
5.6.±.0.7
6.1+0.7

5
13. 8+4·. 7 5
12.3.±.3·3
7.4.±.2.3

9.1.±.1.3
6.9.±.0.9
6.J.±.0.6

3
15.1.±.2·72
1 7 • 3.±.5 • 0 5
11.J.±3·5

o.o+o.o
0.0.±.0.0
o.o+o.o

l.6+0.64J
l.5+0.52
0.5.±.0.2

o.s+o.4
l.o+o.4
0. 3±,0 .1

0.7£0.7
1. 6+0. 53
1.6+0.9

1.9.±.0.3
2.5.±.0.4
5.4.±.1.7

2
0.5.±.0.l
l.5+0.03
o.s.±.o.4

Piloerection
(No positive/No observed)
24
48
72

0/12
0/12
0/12

12/21
6/9
5/9

15/15
15/15
15/15

9/9
9/9
9/9

27/27
27/27
16/16

12/16
15/16
16/16

Ptosis Time
24
48
72

o.o.±.o.o
o.o+o.o
o.o.±.o.o

193.±,101
119.±.119
33.±33

28+21
o.o.±.o.o
o.o.±.o.o

2
763.±,2192
670+2902
411.±.205

101+28
87+30
384.±,92

1768+21 5
1178+175;
1179.±,193

31.2+1.7
J6.9+7.4
Lt6.8+1.4

2.6+0.7
25.3.±,2.7
30.9.±.2.l

45.8.±.0.9;
68.4.±,2.55
82.0.±,3.0

12.8+1.5
26.5+1.5
31.8.±,3.0

36.4.±.1.1§
56.0.±.2.85
72.9.±.2.6

Weight Loss
24
48
72

\.0
VI

Table 5 - Continued

·'
Hypothermia
24

+0.5±0.1
+O.l+O.l
+0.2+0.1

l~8

72

1.87+0.06
1.75+0.07
1.70+0.08

1. 78+0 .13
2.40+0.25
2
J.05+0.40

2.05+0.07
1.88+0.06
1.61+0.15

1.

lmA for 15 seconds.

2.

Significantly different from non-lesioned controls based on Student's It
(pLo.05).
Significantly different from non-lesioned controls based on Student's It
(pL0.02).
Significantly different from non-lesioned controls based on Student's It
(pL0.01).
Significantly different from non-lesioned controls based on Student's It
( p .L 0. 001 ) •

J.

4.
5.
6.

1.50+0.0J 5
2.58+0.514
4.02+0.75

I test
I test
I test
I test

All data are expressed in terms of means and standard errors unless otherwise indicated.
The number of animals employed in each group is indicated as the denominator
of the fraction used to express the occurrence of piloerection~
Ptosis time is
expressed in seconds, weight loss in grams and hypothermia in degrees centigrade •
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72 hours.

These data are shown in Table 5. · The lesioned

groups showed significantly less 72 hour morphine withdrawal
aggression.
2.

These data are given in Table 4 .

Effect of large nigro-striatal lesions
Large nigro-striatal lesions made after the terminal

dose of morphine in rats dependent upon 200 mg/kg/day resulted in increased ptosis time and weight loss.
of these data by the Student's ' t '

Analysis

test showed a significant

(p.L0.001) increase in ptosis time and weight loss at 24, 48
and 72 hours of withdrawal.

Hypothermia in the nigro-stri-

atal lesioned rats showed a significant (pL0.001) increase
at 72 hours.

A significant (p.L.0.05) lesion effect was ob-

served for wet shakes and writhing in non-addicted rats.
Weight loss was also seen in non-addicted lesioned rats.
These results are summarized in Table 6.

Morphine withdraw-

al aggression was decreased by the lesion as shown in Table

4.
A similar lesion effect was seen in rats dependent up on 405 mg/kg/day of morphine.
nificantly (pL0.05) at 24,

Writhing was decreased

si ~ -

48 and 72 hours in those rats

receiving extensive nigro-striatal lesions after the production of dependence.

The Student's ' t ' showed significant

(pL.0.001) lesion induced increases in ptosis time and
weight loss at 24, 48 and 72 hours as compared to
sioned addicted controls.

non-le~

Withdrawal hypothermia signifi-

cantly increased at 48 (pLO.Ol) and 72 (pL0.001) hours as
compared to non-lesioned counterparts.

These results are

Table 6.

Narcotic Withdrawal Symptoms After Large Nigro-Striatal Lesions 1 Following the
Terminal Dose of Morphine Sulfate

Non Addict e d
Symptoms 6
(Hours of
Withdrawal)

Addicted

200 mg/kg/day
Non
Lesioned

405 mg/kg/day

Non
Lesioned

Lesioned

Non
Lesioned

Lesioned

2.4+0.7

2.0+0.J
5.6+0.7
6.1+0.7

5.2+1.9
1J.J+4.4
8.5+2.4

9.1+1.J
6.9+0.9
6.J+0.6

6.1+1.9
10.5+1.7
9.1+2.J

4
l.J+0.44
2.J+0.6
l.J+o.6 2

0.5+0.4
l.0+0.4
O.J+O.l

1.8+1.J
0.5+0.2
2.4+1.J

1.9+0.J
2.5+0.J.i.
3.2+0.9

Lesioned

Wet Shakes
24
48
72

0.2+0.1
0.2+0.1
0.2+0.1

2.2+0.4 5

2.6+0.4~

Writhing
24
48
72

o.o+o.o
o.o+o.o
o.o+o.o

Piloerection
(No positive/No observed)
21+
0/12
48
0/12
72
0/12

2L~/25

10/10
10/10

15/15
15/15
15/15

2
o.o+o.o
o.7+0.7 2
o.0+0.02

9/9
9.9
7/7

27/27
27/27
16/16

8/8
7/7
6/6

l25J+l665
1288+1785
1511+1765

101+28
87+JO
201+60

1800+005
1740+605 .
l800+oo5

Ptosis Time
24
L18

72

o.o+o.o
o.o+o.o
o.o+o.o

l5J+88
231+92 2
:355+21J

28+21
O+O
O+O

\0
(X)

&

I

I
t

Table 6 - Continued
Weight Loss
24
J.i.8
72

J0.0+2.1 ·
55.3+5.o
70.2+6.3

2.6+0.7
25.3+2.7
J0.9+2.1

J7.8+J.5~

68.7+5.l
89.1+5.or

12.8+1.5
26.0+1.5
J2.8+J.O

J6.8+2.25
54.7+2.25
69.8+2.25

2.05+0.07
1.88+0.06
1.35+0.10

2.J8+o.4o
4
4.88+1.035
6.98+1.81

Hypothermia
24
48
72

0.00+0.16
o.6J+0.4J
0.27+0.42

1.87+0.06
1.75+0.07
1.70+0.08

1.55+0.17
J.00+0.705
J.L~5+0.41

1.

2 mA for JO seconds.

2.

Significantly different from non-lesioned controls based on Student's It I test
(p.£'0.05).

J.

Significantly different from non-lesioned controls based on Student's ' t ' test
( p .L 0. 02).
Significantly different from non-lesioned controls based on Student's It I test
(pL0.01).
Signi fi c a ntly different from non-lesione d controls by the Student's It I test
(p L0. 001).

4.
5 •·
6.

All d a t a a re expre s sed in terms of means and standard errors unless otherwise indicat e d.
The number of animals employed in each group is indicated as the denominator
of the fr a ction used to express the occurrence of piloerection.
Ptosis time is ex~
pressed in seconds, wei g ht loss in gra ms and hypothermia in degrees centi g r a de.
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summarized in Table 6.

The nigro-striatal °lesioned groups

exhibited reduced morphine withdrawal aggression.

These

data are represented in Table 4.
c.

Lesions made during the withdrawal period.
l.

Effect of small nigro-striatal lesions
The production of small,

lmA l5 sec , lesions of

the nigro-striatal pathway made at 48 hours after the last
morphine injection produced an increased occurrence of 72
hour withdrawal symptoms as shown in Table 7.

Wet shakes

and writhing were significantly (pLO.Ol) increased as compared to non-lesioned controls by the Student's

' t ' test.

This same test showed a significant (p~O.OOl) lesion effect
on ptosis time and weight loss.
2.

Effect of large nigro-striatal lesions
Large,

2mA JO sec ,

lesion of the nigro-striatal

tract produced increases in some withdrawal symptoms.
These data were analyzed by the Student's

' t ' test.

Signif-

icant (pL0.01) increasES in ptosis time and weight loss were
seen in lesioned subjects as compared to their non-lesioned
counterparts.
d.

These results are summarized in Table 7.

Modification of narcotic withdrawal symptoms by apomorphine
l.

Effect of apomorphine on narcotic withdrawal symp-

toms in the intact dependent rat
Dependent rats,

405 mg/kg/day of morphine, were o b-

served for the occurrence of •withdrawal symptoms and then

:·.

Table 7.

Nigro-Striatal Lesioning at Forty-Eight Hours After the Last Morphine Sulfate
Injection: Effect on Seventy-Two Hour Withdrawal Symptoms

Addicted

Non Addicted
Sym.etoms 7

Non
Les1oned

Wet Shakes
0.2+0.1
Writhing
o.o+o.o
Piloerection
0/12
(No positive/No observed)
Ptosis Time
o.o+o.o
Weight Loss

-

Small
Lesion 2

Large ·
Lesion 3

Non
Lesioned

Small
2
Lesion

Large J
Lesion

6
J.0+0.6
i.6-+"o.64
9/17

2.2+0.4
l.J+0.4
24/25

6.J+0.6
J.2+0.9
16/16

5
17.5+3.75
O.J+O.l
20/20

lJ.4+4.J
0.8+0.8
7/7

153+88
J0.0+2.1

201+60
J2.9+J.O

6
1Jl0+12J6
54.4+2.4

6
1414+2556
51.7+J.4

126+76
Jl.2+1.7

1.

Rats were dependent upon 405 mg/kg/day of morphine sulf'ate.

2.

lmA 15 sec nigro-striatal lesions.

J.

2mA JO sec nigro-striatal lesions.

4.

Significantly different from non-lesioned controls based on Student's ' t ' test (pL0.02)

5.

Significantly different from non-lesioned controls based on Student's ' t ' test (pL0.01)

6.

Significantly differe nt from non-lesioned controls based on Student's 't' test (pL0.001)

7.

All data are expressed in terms of means and standard errors unless otherwise indicated.
The nwnber of animals employed in each group is indicated as the denominator of the
fraction used to express the occurrence of piloerection. Ptosis time is expressed in
seconds, weight loss in grams and hypothermia in degrees centigrade.

1--'
0
1--'
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after being injected with apomorphine,

re-observed.

sults for this experiment are given in Table 8.

The re-

The paired

' t ' test was used to determine if apomorphine had a significant effect on the symptoms of narcotic withdrawal.

Wet

shakes were significantly (p L 0. 05) reduced by apomorphine
(l.25 mg/kg) at 24, 48 and 72 hours after the terminal dose
of morphine.

The other symptoms of morphine withdrawal were

not significantly affected by this treatment.
2.

Effect of apomorphine on narcotic withdrawal symp-

toms in rats with nigro-striatal lesions made after the production of dependence.
Small (lmA 15 sec ) nigro-striatal lesions pcoduced
after the terminal dose of morphine were observed to increase the severity of the withdrawal syndrome.
5.)

(See Table

The effect of an injection of apomorphine (l.25 mg/kg)

on the withdrawal syndrome in rats with nigro-striatal lesion made after the terminal dose of morphine is shown in
Table 9 .

Wet shakes were decreased at 24,

48 and 72 hours

with significant (pto.05) reductions occurring at both 48
and 72 hours when compared by the paired ' t '
drug levels.

test to pre-

Apomorphine failed to significantly affect

the other symptoms of withdrawal in these lesioned rats.
2)

Modification of Narcotic Withdrawal Symptoms by Medial
Fore Brain Bundle Lesions
a..

Lesions made after the production of morphine dependence

Table 8.

The Effect of Apomorphine on Narcotic Withdrawal Symptoms in the Intact Dependent
Rat
Time Since the Terminal Dose of Morphine
Twenty-four hours

S}:'.:mEtoms 5

.Pre-Drug

Wet Shakes
6.2+1.5
Writhing
1.1+0.J
Piloerection
21/21
(No positive/no observed)
Ptosis Time
434+112
Hypothermia
2.08+0.34
Weight Loss
25.0+l.8
1•

Post
1
AEomo q:~hine

Seventy-two hours

Forty-eight hours
Pre-Drug

Post
1
A:eomor:ehine
4

2.0+1.l 3
o.4+0.1
21/21

5.1+1.9
l.h+o.5
10/10

2.8+1.l
1.3+0.4
10/10

867+134
2.48+0.30
25.4+2.o

125+51
1.95+0.35
31.h+J.5

379+114
1.92+0.35
33.J+3.9

Post
1
Pre-Drug Apomorphine ·
5.6+0.9
l.J+0.4
10/10

3.0+0.8 3
o.6+o.4
10/10

95+63
157+58
1.24+0.39 l.lO+O.J8
27.6+3.o Jl.l+J.l

. Apomorphine hydrochloride 1.25 mg/kg administered fifteen minutes prior to observation.

2.

Rats were dependent upon 405 mg/kg/day of morphine sulfate, injections were given
three times a day.

J.

Significantly different from pre-drug based on Paired ' t ' test (p Lo.05).

4.

Significantly different from pre-drug based on Paired

5.

All data are expressed in terms of means and standard errors unless otherwise indicated.
The number of animals employed in each group is indicated as the denominator
of the fractions used to express the occurrence of piloerection.
Ptosis time is expressed in seconds, weight loss in grams and hypothermia in degrees centigrade.

1

t

1

test (p

L..

o. 01).

f--'

0

\....)

Table 9.

1
The Effect of Apomorphine on Narcotic Withdrawal Symptoms in Rats With NigroStriatal Lesions2 Made After the Terminal Dose of Morphine3
Time Since the Terminal Do se of Morphine Sulfate
Forty-eight hours

Twenty-four hours

SymEtoms5

Pre-Drug:

15. l+lt. l
Wet Shakes
Writh ing
0.7+0.4
Pilo erection
9/9
(No positive/No observed)
Ptosis Time
1800+0
Hypothermia
2.J+0.4
Weight Loss
J0.7+2.2

Post
1
Apomorphine Pre-Drug
7.8+1.5
O.O+O.O
9/9

l.).O+J.l
o.4+o.4

1800+0
2.8+0.2
J6 .2+2.0

1800+0
J.8+0.5
60.1+2.J

9/9

Seventy-two hours

Post
1
AEomorEhine
6.0+l.4
o.o+o.o
9/9

4

1785+144.J+0.4
6J.0+2.0

Pre-Drug

Post
Apomorphine 1

4

9.l+J.8
o.o+o.o
8/8

2.5+1.l
o.o+o.o
8/8

1800+0
6.4+0.9
81. O+J. 0

1740+35
6.6+0.9
81.6+2.4

1.

Apomorphine hydrochloride 1.25 mg/kg administered fifteen minutes prior to observation.

2.

lmA 15 sec nigro-striatal lesions.

J.

Rats were dependent upon 405 mg /kg/day of morphine sulfate, injections were given
twice a day.

4.

Significantly different from pre-drug based on Paired

5.

All data are expressed in terms of means and standard errors unless otherwise indica.ted.
The number of animals employed in each group is indicated as the denominator
of the fractions used to express the occurrence of pilo e rection.
Ptosis time is expressed in seconds , weight loss in grams and hypothermia in degrees centigrade.

1

t

1

test (p LO. 05).

f-'
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1.

·

Effect of small medial fore brain bundle lesions
Withdrawal symptoms were found to be modified

by small (lmA 15 sec ) medial fore brain bundle lesion
when they were made after the terminal dose of morphine;
these results are shown in Table 10.

The Student's

't'

test

was used to analyze the difference between the mean of the
lesioned groups and that of the non-lesioned addicted controls.

Wet shakes were found to be significantly (pL 0.05)

increased at 48 hours of withdrawal while writhing was significantly (pL0.02) decreased at both 24 and 48 hours after
the terminal dose of morphine.
cre~ses

Significant (pL 0. 001) in-

were seen in ptosis time and weight loss at 24,

and 72 hours of morphine withdrawal.

48

Hypothermia was found

to significantly (p.LO.Dl) increase at 72 hours of morphine
withdrawal.

The lesion by itself produced ptosis and weight

loss in non-addicted rats.
were found to decrease

Medial fore brain bundle lesions

soci~l

aggression seen at 72 hours

of withdrawal; these results are shown in Table 4.
2.

Effect of large medial fore brain bundle lesions
The effect of large (2mA JO sec

) medial fore

brain bundle lesion on morphine withdrawal are shown in
Table 10.

At 48 hours of withdrawal a significant (p.L0.001)

increase in wet shakes was observed; the Student's ' t ' test
was used to determine significance.

Writhing was signifi-

cantly (pL0.05) decreased at both 48 and 72 hours of withdrawal.

The Student's ' t '

test showed ptosis time and

weight loss to be significantly (pL0.001) increased in the

Table 10.

The Effect of' Medial Fore Brain Bundle Lesions on the Narcotic Withdraw! Syndrome

Addicted

Non Addicted
Symptoms5
(Hours of'
W:ithdrawal

Lesioned

Lesioned

Non
Lesioned

lmA 15 sec

2mA JO sec

Non
Lesioned

lmA 15 sec

2mA JO sec

0.2+0.3
0.2±0.3
0.2±0.3

1.25+0.7
0.75+0.3
1.25.±.0.9

0.7+0.4
2.0+0.8
1.1±0.9

9.1+1.3
6.9+0.8
6.3+0.9

10.1+3.4
14.5+3.0
8.8±2.7

10.2.±.4.84
16.5+2.l
20.0.±.8.6

o.o+o.o
o.o.±.o.o
o.o.±.o.o

0.75+0.3
0.62+0.2
0.62+0.3

o.o+o.o
O.J+0.3
o.o+o.o

1.9+0.3
2.5+0.4
J.2±0.9

0.3+0.2
4.5+2.6
0 .. 50+0.32

0.2+0.2
1
0.1+0.1
1
0.0±0.0

Piloerection
{No positive/No observed)
24
0/12
48
0/12
72
0/12

5/8
5/8
8/8

2/L~

27/27
27/27
16/16

6/6
6/6
6/6

8/8
7/7

4/4

Ptosis Time
24
48
72

2
562+215
615-:;:-284 1
576+258

101.±.27
87+30
201+60

4
1533+1?84
1033.±.2b04
1270±.255

4
1800±0004
1611±1444
1800+000

Wet Shakes
24
48
72
Writhing
24
48
72

o.o+o.o
o.o+o.o
o.o+o.o

5/6
4/6
570±]96
1600+1264
1058+3393

4
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~

Continued

Hypothermia

24
48
72

O.Ol+0.08
+0.08+0.16
O.Jl+0.11

+O.l+O.l
O.O+O.l
o.4:;0.2

2.04+0.07
1.8+0.0J
l.J5+0.l

l.5J+O.J9
l.90+0.J6
J.J0+0.573

12.4+1.4
25.5+1.6
J2.8+J.O

J6.8,±.l.74
59. 6±1. 61+
7J.8±.l.7

2.50+1.92
4.62+0.9
2
4.67±2-5

Weight Loss

4J.2+2.0
61.7:;2.5
67.5+6.5

24
48
72
1.

L~5.4+4.J

62.J+4.9
72.8+6.4

4

4

J9.6±_2.24
59.4±.J.64
62.7±.7.1

Significantly different from non-lesioned controls based on Student's ' t ' test

(pL0.05).
2.

Significantly different from non-lesioned controls based on Student's ' t ' test

(p L0.02).

J.

Significantly different from non-lesioned controls based on Student's ' t ' test
(pL

4.

0.01).

Sig ni f icantly different from non-lesioned controls based on Student's ' t ' test

(p.L0.01).
5.

All data are expressed in terms of means and standard errors unless otherwise indic at e d.
The number of a nima ls employed in each group is indicated as the d e nominator
of th~ fractions used to express the occurrence of piloerection.
Ptosis time is express e d in seconds, weight loss in grams and hypothermia in degrees centigrade.
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medial fore brain lesioned withdrawn rats.

Hypothermia was

significantly (p £ 0. 02) increased in the lesion groups.
Ptosis and weight loss resulted from lesioning non-addicted
rats.

Morphine withdrawal a g gression was decreased by these

_large medial fore brain bundle.

These results are sununar-

ized in Table 4.
b.

Small lesions made during the withdrawal period
The effects of small (lmA 15 sec ) medial fore bra in

bundle lesions made at 48 hours on narcotic withdrawal
symptoms at 72 hours are sununarized in Table 11.
significance was determined by the Student's

Statistical

' t ' test.

Ptbsis time, weight loss and hypothermia were found to significantly (p Lo.01) increase in medial fore bra in bundle
lesioned rats as compared to non-lesioned addi c ted controls.
D.

Discussion
The results from these experiments sugg e s t

a role for

dopaminergic nigro-stria tal fibers in mori:,hine ivi thdrawal .
Nigro-striatal lesioning prior to the production of morphine dependence resulted in increased wet shakes, ptosis
and weight loss at various intervals after the terminal
doses of morphine.

Similar increases in wi thdrawa _l symptoms

were observed when small (lmA 15 sec

) lesions of the nigro~

striatal pathway were made after the terminal dose of morphine.

Ptosis time, weight loss and hypothermia were in-

creased when large (2rnA JO sec ) nigro-striatal pathway lesions were produced after the production of morphine dependence.

Lesions of the nigro-s t riatal bundle during the

Table l _l.

Narcotic Withdrawal Symptoms at Seventy-Two Hours After Small Lesions of the
Medial Fore Brain Bundle 1 at Forty-Eight Hours

Non Addicted
Symptoms 7

Non
Le sioned

Lesioned

Wet Shakes
Writhing
P iloerec tion
(No positive/No observed)
Ptosis Time
Weight Loss
Hypothermia

0.2+0.J
O.O+O.O
0/12
O.O+O.O

-

-

Addicted

-

Non
LesionedJ

Lesioned

2 .6+0.7
0.8+0.3
0/12

6.J+0.6
3.2+0.9
16/16

6.1+0.9
1.5+1.2
16/16

J8J+208
Jl.9+.08
O.Ol+.08

201+60
J2.9+J.O
1.35+0.l

2

4

1043+164~
52.6+J.46
2.97+0.4

1.

lmA 15 sec

2.

Twenty-four hours after medial fore bra in bundle lesioning.

J.

Seventy-two hours after the last injecti on of morphine sulf'ate, 135 mg/kg.

4.

Seventy-two hours after the last injection of morphine sulfate, 135 mg/kg, and
twenty-four hours after the production of the lesion.
Significantly different from non-lesioned addic ted controls by the Student's It
test (p L 0,02).

5.

medial fore brain bundle lesions.

I

6.

Significantly different from non-lesioned addicted controls by the Student's It I
test (p L0 .01).

7.

All data are expressed in terms of means and standard errors unless otherwise indicated.
The numb er of animals employed in e2ch group is indicated as the denominator
of the fractions used to express the occurrence of piloerection.
Ptosis time is expressed in seconds, weight loss in grams and hypothermi a in degrees centigrade.
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withdrawal period, 48 hours after the terminal dose of morphine, resulted in increased wet shakes,ptosis time and
weight loss.
(Anden

tl

Apomorphine,

a dopamine receptor agortist

al., 1967; Ernst, 1967), reduced "\'!et shakes in

both intact and nigro-striatal lesioned dependent rats.
Several mechanisms may possibly underly the enhanced
withdrawal symptoms in nigro-striatal lesioned subjects.
An increased denervation supersensitivity,

changes in recep-

tor activity and alterations in the balance between several
putative neurotransmitters are mechanisms worthy of consideration.
One possible explanation for the enhanced withdrawal
symptoms induced by nigro-striatal lesioning can be offered
in terms of a denervation supersensitivity • .

It is a well

recognized phenomenon that after pharmacological or surgical
denervation in the peripheral nervous system,

the response

of the target organ to a transmitter can be greatly augmented.
Analogously,

it has been suggested that physical dependence

might be a manifestation of a central denervation supersensitivi ty and as a result the withdrawal phenomena would
reflect a state of rebound hyperexcitability (Jaffee and
Sharpless, 1968).

If the withdrawal symptoms that were seen

to increase involve dopaminergic pathways,

then nigro-

striatal lesioning could induce an additional degree of
supersensitivity in this pathway and thus enhance the withdrawal symptoms.

The production of a biochemical lesion of

catecholamine nerve terminal by 6-hydroxy-·dopamine has been

111

reported to exacerbate the signs of morphine withdrawal in
mice {Friedler et al., 1972) and in rats

1973).

(Bhargava et al.,

These investigators have suggested that the enhanced

withdrawal phenomena observed in their experiments may be
due to an increased denervation supersensitivity produced
by 6-hydroxydopamine treatment.
Receptor activation may be in part responsible for the
expression of several withdrawal symptoms.

Nigro-striatal

lesions lead to increased wet shakes and a decreased activation of striatal dopamine receptors, whereas apomorphine,

a

dopaminergic receptor stimulant, decreases the occurrence
of wet shakes.

These data point to a major role for dopa-

mine receptor activity in the expression of narcotic withdrawal wet shakes.

An increase in dopamine receptor activity

resulting in decreased symptomology while on the hand decreased receptor stimulation results in the increased occurrence of wet shakes.

The apomorphine induced decrease

of withdrawal wet shakes is in accordance with the results
of Hoffmeister and Schichting (1973).

These investigators

found a decrease in withdrawal wet shakes of the dog after
stimulation of central catecholamine mechanisms with amphetamine and cocaine.

The effect of these drugs was inter-

preted to indicate an antagonism of withdrawal.

Herz

~

al.,

(1974) have shown that the administration of ct-amphetamine,
cocaine,

L-dopa increased levallophan precipitated withdraw-

al jwnping and decreased wet shakes.

The effect of these

drugs was interpreted as a potentiation of withdrawal since

similar changes in withdrawal occurred when. withdrawal was
precipitated in highly dependent rats (Herz et al., 1974).
Following their logic it would be concluded that nigrost~iatal

lesions reduce narcotic withdrawal.

This conclu-

sion does not seem to be justified in view of the fact that
rats receiving a terminal dose of 405 mg/kg/day of morphine
show a higher occurrence of wet shakes than those dependent
upon 200 mg/kg/day of morphine.

It has been reported that

rats de~endent upon JO or 120 mg/kg/day of morphine show no
wet shakes upon withdrawal of the drug (Akera and Brady,

1968).

The increase in wet shakes se e n in those rats re-

ceiving a higher terminal dof.e of morphine tends to parallel
a general increase in other

s~nptoms.

Additional support for the role of denervation supersensitivity and receptor activity in the expression of
withdrawal symptoms comes from the effect of the lesion by
itself.

Nigro-striatal lesioning produced some symptoms

similar to those of narcotic withdrawal.

Lesioned animals

showed wet shakes, writhing, piloerec t ion, ptosis and
weig;ht loss.

The appearance of these withdrawal like symp-

toms is thought to be due to a decrease impulse flow in the
nigro-striatal system and a resultant denervation supersensitivity.

It should be pointed out that the increase in

withdrawal symptoms in the animals lesioned after the production of dependence cannot totally be explained in terms
of the lesion effect a lone.

Lesioning t he nigro-striatal

pathway prior to the production of dependence results in
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increased withdrawal signs when the effect of the lesion alone
is virtually non-exist e nt.
Alterations in the balance between several putative
neurotransmitters have been reported to occur during morphine
withdrawal (Merali ~al.,

1974).

These inv estigators have

shown alterations in the cholinergic and dopaminergic mechanism of the striatum during chronic morphine treatment and
its subsequent withdrawal.

Dopaminergic nigro-s t riatal fi-

bers are known to influence the metabolism of acetycholine
in the neostriatum.

Destruction of this tract results in an

exaggerated response in neostriatal cholinergic neurons to
apornorphine (Fibiger and Grewaal, 1974).

A complex interac-

t i,:>n between morphine induced changes in striatal dopamine
and acetycholine and th o se cha nges induced by nigr6-striatal
lesioning may be in part responsible for the enhanced withdrawal symptoms observed in nigro-striatal lesioned subjects.

Serotonin has also been implicated in the pharma-

cological actions of morphine and in the phenomena of narcotic withdrawal (Shen~ al.,

1970)~

Recently it has been

shown that nigro-striatal fibers are functionally connected
with a serotonergic system (Cools~ al., 1974).

It is thus

possible that the nigro-striatal les i on induced increases
in withdrawal symptoms are the result of alterations in serotonergic and dopamine rgic neuronal systems.
The intense morphine withdrawal a gg ression observed in
response to social g rouping 7 2 hours after the termination
of morphine injections was reduced by the production of
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partial

nigro~striatal

pendence.

lesion prior to the production of de-

Similarly, when lesions of the nigro-striatal

tract were made after the terminal dose of morphine there was
a general decrease in the aggressive response of these animals.

One notable exception occurred when a small (lmA 15

sec.) lesion was placed in rats dependent upon 200 mg/kg/day
morphine after the last injection.

It should be noted that

these results are of a preliminary nature and further investigation is needed.

These results are thus in agreement with

those of Gianutsos ~ ~·

(1973,

1974b),who have shown that

nigro-striatal lesioning blocked morphine withdrawal aggression in thirty-'-day abstine nt rats.

It has been previously

hy;iothesized that social aggression during acute w.i thdrawal
was caused by the hyperactivity of dopaminergic receptors
which have become supersensitized during chronic morphine
administration (Lal . ~~.,
and Lal, 1973).

1971; Lal and Puri, 1972; Puri

The decrease in aggression.appears to re-

sult from the degeneration of dopamine neurons produced by
the lesion,

thus leaving little or no transmitter to be re-

leased onto supersensitized receptors.
Destruction of the medial fore brain bundle in morphine
dependent rats resulted in increased ptosis, temperature and
weight loss.

Although wet shakes were seen to increase at

both 48 hours and 72 hours, the increase was significant only at 48 hours.

Seventy-two hour withdrawal ptosis, weight

and temperature loss were significantly increased when lesions were produced during the withdrawal period.

Wet shakes
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were not affected by these 48 hour lesions~-

These experi-

ments with the medial fore brain bundle suggest a role for
nor-adrenergic and serotonergic mechanisms in narcotic
drawal,

especially ptosis, weight a n d temperature loss.

involvement of the medi a l

The

fore brain b undle in n a rcotic

withdrawal has been previously sug gested (Glick et al.,
Herz et al., 1974).

with~

1973;

It appears that wet shakes are more de-

pendent upon dopaminergic mechanisms,

since medial · fore brain

bundle lesions were effected in significantly increasing wet
shakes at only one time interval.

A role for this noradren-

ergic neuronal system in wet shakes can not be totally ruled
out.

VI.

DISCUSS!OK

Electrolytic lesions of the nigro-striatal dopamine
pathway resulted in decreased striatal dopamine,

loss of

body weight and increased some symptoms of morphine withdrawal.
Increased levels of striatal dopamine were seen 24
hours after both small (lmA 15 sec) and large (2mA JO sec)
lesions of the nigro-striatal tract .•

At four and seven days

after small (lmA 15 sec) lesions the level of striatal dopamine was significantly reduced.

A similar reduction was

otserved four days following a large (2rnA JO sec) nigrostriatal lesion.

These results correspond well with those

of other investigators (Faull~ al., 1969; Anden ~al.,

1972; Agid et al., 1974).
Lesioning of the nigro-striatal pathway resulted in
aphagia and adipsia,

indicated by a loss of body weight.

The histological examination of · the lesion site and the

de~

crease in corpus striatal dopamine produced by the lesion
indicates that the extent of weight loss was dependent upon
the amount of nigro-striatal damage.

Administration of

haloperidol or alpha-methyl-para-tyrosine prior to the production of small (lmA 15 sec) ni gr o-striatal lesions lessened the loss in body weight produced by the lesion.
Lethality and the loss of body weight were reduced in those
animals who were pretreated with haloperidol and morphine
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ll-1

prior to receiving a large (2mA JO sec
sion.

) nigro-striatal le-

An increase in receptor sensitivity, regnerative

sprouting from transected axons and an increase in catecholamine turnover are several possible mechanisms which may be
involved in the recovery of body weight following nigrostriatal lesioning.
Morphine withdrawal wet shakes, ptosis, weight loss
and hypothermia were increased when nigro-striatal lesions
were made either prior to or following . the production of morphine dependence.

Similar changes were observed when the

lesion was made during the withdrawal period.

Apomorphine

effectively induced withdrawal wet shakes in both
nigro-striatal lesioned subjects.

in~act

and

Several mechanisms which

may be responsible for the enhanced withdrawal symptoms in
these lesioned subjects are an increased denervation supersensi tivi ty,

changes in receptor activity and alterations

in the balance between several putative neurotransmitters.
Noradrenergic mechanism also appears to be involved in the
narcotic withdrawal syndrome since destruction of the medial
fore brain bundle in morphine dependent rats resulted in increased ptosis, weight loss and hypothermia.
This study suggests a role for nigro-striatal fibers
in the regulation of body weight and some of the symptomology of morphine withdrawal.

An interaction between the

nigro-striatal system and drugs effect dopamine receptors
is indicated by th e pharmacological modification of lesion
induced weight lo ss.

The increased morphine withdrawal

118

wet shakes, ptosis, hypothermia, weight loss and decreased
aggression further suggest such an interaction.

The

supersensitivity of dopamine receptors may be a useful concept in explaining such interactions.

:VII.

SUMMARY AND CONCLUSIONS

Lesions of the nigra-striatal dopamine neurons system
result in aphagia and adipsia.

The extent of weight loss

in the lesioned animals was dependent upon the amount of
nigro-striatal damage.

A denervation supersensitivity of

striatal dopamine receptors is viewed as being in part responsible for the recovery of nutritive function following
nigro-striatal destruction.

Administration of drugs cap-

able of producing supersensitivity at central dopamine receptors,

alpha-methyl-para-t :;.Tosine, haloperidol and mor-

phine, have been found to facilitate recovery from the lesion effects.
The symptoms of morphine withdrawal were intensified
when the nigro-striatal pathway was destroyed prior to or
following the production of dependence.

Withdrawal wet

shakes, ptosis, weight loss and temperature loss were seen
to significantly increase.

Apomorphine produced a signif-

icant decrease in wet shakes in both lesioned and nonlesioned dependent rats.

These results suggest that with-

drawal wet shakes are dependent upon dopaminergic mechanism.

A denervation supersensitivity mechanism,

changes

in receptor activity and alterations in the balance between
several putative neurotransmitters are mechanisms which may
be useful in explaining the increased withdrawal phenomena.
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Nigro-striatal destruction was found to hav·e decreased the
intensity of seventy-two hour withdrawal agg ression.
Noradrenerg ic mechanisms also appear to be involved
in the narcotic withdrawal syndrome.

The symptoms of ptosis,

weight and temperature loss appear to be at least in part
dependent upon the activity and functional integrity of
medial fore brain bundle.

th~
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